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Background: Coronary Artery Disease (CAD) is highly prevalent in
our population.
Aims and objectives: The STable Angina obseRvational Registry
(STAR registry) aimed to understand the current diagnosis, man-
agement and interventional therapy pattern of stable angina (SA)
subjects in an Indian population.Risk profile STAR India
Study
Eur
S
N¼2079 N¼3
Age 57.0  10.5 61 
Male % 62.1% (1291) 58%
Diabetes 39.7% (825) 18%
Hypertension 69.2% (1438) 62%
Hyperlipidemia 46.8% (974) 58%
Current smoker 14.0% (291) 23%
Family history
CAD
21.1% (438) 43%
PVD 4.1% (85) 7%
CVA/TIA 4.7% (98) 5%
BMI 26.610.6 28
CCS class I 25.1% (522) 39%
CCS class II 63.7% (1324) 49%
CCS class III 10.8% (225) 12%
http://dx.doi.org/10.1016/j.ihj.2013.10.017Methods: The STAR Registry is a prospective, multicenter, obser-
vational study that enrolled 2,079 subjects at 131 sites in India.
Subjects had a provisional diagnosis of SA within 3 months of
enrollment. Demographics, medical history, diagnostic tests and
results, and drugs prescribed were collected. The Morise and Jalisi
pretest scoring system was used to define low, intermediate or
high probability of significant CAD related to outcomes.
Results: As in the Euro Heart Survey and FAME-2 Study, the STAR
Registry population had significant risk factors and comorbidities
with diabetes standing out prominently (see table)
The probability of CAD was low for 7.2%, intermediate for 41.7%
and high for 51.1% of subjects.
Rates of drug consumption were as follows: statins, 86.1%; b-
blockers, 70.3%; ACE inhibitors/ARBs, 64.5%; antiplatelet drugs,
87.7%; diuretics, 19.6%; and nitrates, 45.7%.
Tests conducted included ECG, 92.8%, baseline echocardiogram,
43.8%. The rate of ischemia assessing tests, like exercise stress
test, 11.8%; and CT/angiography, 7.5% were low.
Conclusion:As in studies ofWestern populations, we observed high
rates of co morbidities and risk factors. Medical management rates
werehigh,butdiagnosticworkupwas low.Thismayhavesignificant
influence on the outcomes especially in high risk probability group.o Heart
urvey
FAME-2 Study
779 PCI ¼ 447 OMT ¼ 441
11 63.59.3 63.99.6
79.6% 76.6%
27.5% 26.5%
77.6% 77.8%
73.9% 78.9%
19.9% 20.4%
48.3% 46.9%
9.6% 10.7%
7.4% 6.3%
5 28.34.3 28.44.6
18.35% 22.3%
45.6% 44.8%
17.9% 14.8%
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) S 1eS 3 2S2CD40 gene -1(C/T) polymorphism in coronary
artery disease
Sapna Singh, S. K. Gupta, Alpana Saxena, Rashid Mir, Sameer
Ahmed
Maulana Azad Medical College, New Delhi
Background: CD40 gene is located on chromosome 20 (q12-
q13.2), belonging to the tumor necrosis factor superfamily and
is widely expressed on endothelial cells, smooth muscle cells,
monocytes, macrophages, dendritic cells, fibroblasts etc. A C/T
SNP in the 5’ untranslated region of CD40 located at the -1 posi-
tion within the kozak sequence (rs 1883832) is found to be asso-
ciated with higher plasma levels of sCD40L and indicates an
increased risk of CAD. Hence, we studied CD40 polymorphism as
it may be a potential marker to identify and manage
atherosclerosis.
Aims and objectives: To find the association of CD40 gene (-1 C/T)
polymorphism and coronary artery disease.
Methods: CD40 gene polymorphism was studied in 80 angio-
graphically proven CAD patients, out of which 64 were unstable
angina patients and 16 were acute MI patients. CD40 gene (-1C/T)
polymorphism was studied by PCR-RFLP using standard primers
and conditions.
Results: The CC genotype and C allele frequency of the CD40 gene
is significantly higher than CT and TT genotype and T allele in
both unstable angina patients and MI patients. The frequency of
CC, CT and TT allele in unstable angina was 36/64 (56.25%), 19/64
(29.68%) and 9/64 (11.25%) respectively with p-value < 0.00. The
frequency of CC, CT and TT allele in acute MI was 8/16 (50%), 7/16
(43.75%) and 1/16 (6.25%) respectively with p-value < 0.01.
Conclusion:Our studysuggests that theCD40 (-1C/T)polymorphism
was associatedwith increased risk of coronary artery disease. The T
to C change in the CD40 (-1C/T) gene carries the risk of CAD.Comparison between the effect of atorvastatin
and rosuvastatin on oxidative stress, in patients
with coronary artery disease and the role of
CYP3A5 gene polymorphism on the same
K. G. Chengappa, Rajnish Avasthi, Gajendra Singh Ranga,
B. D. Banerjee, Tusha Sharma
University College of Medical Science and GTB hospital, Delhi
Background: Thrombolytic and revascularization therapies, along
with statins have formed a mainstay in treatment and prevention
of CAD and ACS. Among the statins, rosuvastatin has been shownTable 1 e Plasma lipid concentrations and markers of oxidativ
Marker Control Group 1 (Atorvastatin 40 mg) C
Before treatment After treatment
TC 151.6724.71 180.7726.29 131.8327.46
LDL-C 99.0728.65 119.0022.26 69.7724.82
HDL-C 40.438.75 36.605.58 37.936.61
TG 121.6338.65 128.3756.55 117.6049.32
VLDL 25.3010.50 25.3010.50 23.479.86
MDA 185.8915.52 94020.52 39330.12
FRAP 0.2240.30 0.1120.13 0.1480.28
GSH 0.727.34 0.169 0.23 0.2320.14to be more efficacious than atorvastatin in many studies. Gene
polymorphisms that can possibly affect the metabolism of statins
and thus their efficacy is an area of increased interest.
Aim: To compare the effects of atorvastatin and rosuvastatin with
regards to levels of serum lipids and oxidative stress markers in
the context of CYP3A5 polymorphisms.
Methods: 152 patients were screened according to our inclusion
and exclusions criteria and 60 statin naı¨ve patients were chosen
as our study group. The 60 were randomized into two groups of 30
each and an age matched control group of 30 was also selected.
One treatment group was chosen to receive atorvastatin and the
other received rosuvastatin. Baseline lipid profiles, oxidative
stress (MDA, FRAP, GSH) markers and CYP3A5 polymorphisms
were recorded. The study groups were followed up at 4 and 8
weeks where repeat blood tests were done. At the end of 8 weeks,
the data collected was compiled and statistically analyzed.
Results: Both atorvastatin and rosuvastatin after a short follow up
of 8 weeks showed significant effects on improving the lipid pro-
files and decreasing oxidative stress markers (MDA, FRAP). Rosu-
vastatin showed a significantly higher propensity to increase
antioxidant levels (GSH). The improvement in Oxidative stress
markers is independent of the action on the lipid profile in a short
term follow up. Genetic polymorphisms had no significant effects
on lipid profiles or oxidative stress markers.
Conclusions: Both Atorvastatin and Rosuvastatin are equally
efficacious in improving lipid profile and Oxidative stress levels.
The CYP 3A5 polymorphism has showed no significant effect on
the action of these drugs.CYP 450 2C19 polymorphisms in Indian patients
with coronary artery disease
Sudhir Shetkar, Sivasubramaniyan Ramakrishnan, Sandeep Seth,
Puneet Chandra, Sunil K. Verma, Balram Bhargava, V. K. Bahl
AIIMS, New Delhi
Background: Dual antiplatelet therapy is cornerstone in the
management of acute coronary syndromes (ACS) and prevention
of stent thrombosis (ST). Genetic polymorphisms in CYP2C19 gene
involved in hepatic activation of clopidogrel leads to clopidogrel
non-responsiveness and may influence clinical outcomes. These
polymorphisms in CYP2C19 gene and their impact on clinical
outcome in coronary artery disease (CAD) have not been studied
in Indian population.
Methods: We studied 110 consecutive patients (mean age 55.7 
10.7 years; 90% male) taking clopidogrel with angiographically
proven CAD for various genetic polymorphisms in CYP2C19 gene.e stress before and after statin treatment.
hange (%) Group 2 (Rosuvastatin 10 mg) Change (%)
Before treatment After treatment
27% 190.2043.93 109.8334.85 42%
41.3% 124.0037.19 83.7726.76 32.44%
3.6% 36.437.74 39.875.80 9.4%
8.3% 147.4079.58 117.9754.38 19.9%
7.2% 29.7716.37 23.5710.88 20.8%
59% 245722.06 54434.24 77.3%
31.9% 0.0820.16 0.0910.11 12.3%
43.1% 0.1080.16 0.1910.20 75%
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) S 1eS 3 2 S3Relationship between loss of function mutation and clinical pre-
sentation with recurrent ACS including ST was analyzed.
Results: Out of 110 patients, 26 (23.64%) had normal genotype,
52(47.23%) loss of function mutation *2 and 39 (35.45%) gain of
function mutation *17, 7 (6.36%) patients were undefined metab-
olizers (*2/*17) which were excluded from analyses. Final analyses
included 103 patients, with 45 (40.90%) having loss of function.
Overall 51 patients had ACS, with 27 developing recurrence while
on clopidogrel. The prevalence of loss of function mutation was
no different between the group with recurrences and those
without recurrences (55.6% vs. 50%, p¼0.7). Two patients devel-
oped ST while on clopidogrel; both had loss of function mutation.
Conclusion: CYP2C19 gene polymorphisms are common in Indian
population. Loss of function mutation status did not affect the
clinical outcomes. A larger study also considering P2Y12 receptor
polymorphisms together with platelet activity testing, may be
required to establish the role of CYP2C19 gene polymorphisms in
clinical practice.Prevalence and severity of asymptomatic
coronary artery disease and carotid artery
disease in patients with peripheral vascular
disease
Chandrakant Upadhyay, Shoeb Nadeem, Pankaj Patil,
Anup Taksande, Ajay U. Mahajan
Lokmanya Tilak Municipal Medical College and General Hospital,
Mumbai, Maharashtra
Objectives: Peripheral vascular disease patients are at high risk of
developing cardiovascular and cerebrovascular events. The pur-
pose of this study was to evaluate the prevalence and severity of
Coronary artery disease and Carotid artery disease in patients
with Peripheral vascular disease
Methods: We studied 56 (45 males and 11 females) patients with
peripheral vascular disease of lower limbs admitted in our insti-
tution between August 2012 to April 2013. These patients did not
have symptoms of angina or dyspnea. Coronary angiography and
carotid Doppler study was done in all patients during their hos-
pital stay.
Results: 25 of 56 patients (44.7%) had significant CAD, 6 patients
(10.7%) had significant carotid artery lesion and 14 patients (25%)
had both. In patients with significant CAD 13 patients (52%) had
severe CAD (left main or tripple vessel or proximal LAD lesion). 2
patients (8%) had left main, 7 patients (28%) had triple vessel
disease and 4 patients (16%) had proximal LAD lesion corre-
sponding to 33.3% of total cohort. Among the 14 patients with
both lesion, 9 (64%) had severe CAD of which 1 patient (9%) had
left main, 5 patients (35%) had tripple vessel disease and 3 pa-
tients (21%) had proximal LAD lesion. The percent of patients
with severe CAD (left main, 3 vessel or proximal left anterior
descending lesion) among those with Carotid artery disease was
higher (64%) compared to those without Carotid artery disease
(52%).
Conclusions: Severe and asymptomatic Coronary artery disease
and Carotid artery disease are quite prevalent in patients with
Peripheral vascular disease.. Cost-effective strategies to detect
asymptomatic Coronary artery disease and Carotid artery disease
in patients with peripheral vascular disease need to be investi-
gated in large multicenter studies.Comparison of fractional flow reserve and stress
myocardial perfusion imaging in assessing the
functional significance of coronary stenoses in
patients undergoing coronary angiography
Dileep Tiwari, R. R. Mantri, Rajneesh Jain, S. C. Manchanda,
Promila Pankaj
Sir Ganga Ram Hospital, New Delhi
Background: Several studies have been reported about the use-
fulness of Fractional Flow Reserve (FFR) to assess the functional
significance of moderately severe coronary stenosis. However
there is no published study available from India.
Aims and objective: The purpose of this study was to compare FFR
with stress myocardial perfusion imaging in moderately severe
coronary stenosis and to determine the role of FFR in decision
making of coronary revascularization in Indian patients under-
going coronary angiography.
Methods: Patients of both sex, above the age of 18 years and who
had moderately severe coronary stenosis (50-70%) on quantita-
tive coronary angiography (QCA) were included in this study. FFR
was measured, using 0.014 inch sensor tipped high fidelity
pressure wire (Radi Medical Systems Inc, Uppsala Sweden), at
baseline and during maximal hyperemia produced by intrave-
nous adenosine. FFR value >0.8 was considered negative (non
ischemic group) and FFR 0.8 was taken as positive (ischemic
group). Stress 99mTc-tetrofosmin scintigraphy was performed
within 24 hours of FFR measurement using intravenous adeno-
sine as per standard stress/rest protocol. Images were taken by
standard gamma camera.
Results: Total 50 patients were enrolled. The mean age was 56.84
years, ranging from 37 - 75 years. 33 (66%) weremales and 17 (34%)
were females. 25 (50%) patients were hypertensive, 17 (34%) were
diabetics and 23 (46%) were having dyslipidemia. 28 (56%) patients
presented with acute coronary syndrome (ACS) and 22 (44%) pa-
tients with chronic stable angina. Left anterior descending artery
(LAD) was the most common vessel involved in 20 (40%) patients
followed by Right Coronary Artery (RCA) in 18 (36%) patients and
Left Circumflex (LCx) in 12 (24%) patients. FFR was positive in 25
(50%) patients, stress imaging was positive in 27 (54%) patients
while negative in 23 (46%) patients. The sensitivity of FFR as
compared to stress imaging was 92.6%, specificity was 100%,
positive predictive value was 100% and negative predictive value
was 92%. Though there was a great overlap, the mean percent
diameter stenosis was significantly more severe in FFR positive
ischemic group than non ischemic group (67.12  3.06 Vs 60.48 
5.54) (p<0.001). Percutanious coronary intervention (PCI) was
advised in all FFR positive group. Out of 27 stress imaging positive
patients, PCI was performed in 23 (85.2%) patients, while 2 (7.4%)
were negative on FFR and PCI was not advised. We have avoided
Percutanious coronary intervention in two patients (14.8%), where
stress imaging was positive while FFRwas negative. No significant
effect was found on FFR and stress imaging with mode of pre-
sentation, age, gender and important risk factors for coronary
artery disease. Our data were consistent with other study
reported.
Conclusion: With this small, nonrandomized study, we conclude
that FFR is a useful index to assess the functional significance of
moderately severe lesions on angiography and is also helpful in
decision making regarding coronary revascularization strategy in
Indian patients.
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) S 1eS 3 2S4Prevalence of metabolic syndrome and factors
predicting metabolic syndrome in CAD patients
in a tertiary care center
Archana Sinha, Sudeep Kumar, Aditya Kapoor
Department of Cardiology, Sanjay Gandhi PGIMS, Lucknow, Uttar
Pradesh
Background: Metabolic syndrome (MS) is a constellation of meta-
bolic factors cluster for cardiovascular disease and diabetes melli-
tus. MS has not been studied in detail in north Indian CAD patients.
Aims and objectives of the study: We undertook this study to see
the prevalence of MS and factors predicting MS in CAD patients.
Methods: Two hundred and thirty five consecutive CAD under-
going coronary angioplasty at our institute was included in the
study. MSwas diagnosed as permodified ATP III criteria (at least 3/
5 features).
Results: MS was present in 181/235 (77%) of patients (mean age
56.6  9.6, 193 male, 99 diabetics). Patients with MS were signifi-
cantly older (57.48.6 vs 53.910.2 years¼0.012), had higher SBP
(131.812.5 vs 125.48.4, P<0.001), DBP (82.8 7.1 vs 80.0 7.8,
P¼0.015), serum triglycerides (148.162.5 vs 105.229.9,p<0.001),
total cholesterol (140.4 39.8 vs 124.334.8, p<0.001), LDL
cholesterol (80.031.6 vs 70.514.9, p¼0.010) but significantly
lower GFR (64.314.1 vs 70.114.9,p¼0.010) compared to patients
without MS. They were also having significantly high BMI
(26.74.1 vs 24.65.3, P¼0.002), Mid Upper Arm Circumference
(28.73.0 vs 27.53.5, p¼0.011), waist circumference (97.9  8.2 vs
90.310.2, p<0.001), waist hip ratio (WHR) (1.02  0.05 vs 0.99
0.6), waist height ratio (0.610.07 vs 0.55 0.05, p<0.001) and
conicity index (1.4 0.07 vs 1.33 1.09, p¼0.001) compared to pa-
tients without MS. Patients with and without MS had a statisti-
cally similar intake of energy (2266.4385.4 vs 2360.8451.4,
p¼0.131),fat (86.620.3 vs 87.927.5, p¼0.334), SFA(27.08.8 vs
29.08.9, p¼0.147), MUFA(26.87.9 vs 26.97.9, p¼0.936),
PUFA(32.59.4 vs 32.713.0, p¼0.861),total dietary fiber(18.54.4
vs 17.43.7, p¼0.095),insoluble dietary fiber (13.83.4 vs
13.22.8,p¼0.213), soluble dietary fiber (3.71.0vs 3.50.9,p¼0.175)
and vitamin B12(1.21.8 vs 1.10.7, p¼0.676).On univariate
regression analysis age [OR 1.04 (95% CI 1.01-1.08, p¼0.013)], BMI
[OR 2.7 (95% CI 1.4-5.3), p¼0.004], GFR [OR 2.4(95% CI 1.2-4.8),
p¼0.017], waist height ratio [OR 6.6 (95% CI 1.9-23.5), p¼0.004],and
conicity index [OR 635.1(95% CI 11.1-366.0), p¼002] while on
multivariate regression analysis only GFR [OR 2.4(95% CI 1.1-5.3),
p¼0.029], BMI [ OR 2.7(95% CI 1.2-6.2), p¼0.017] and conicity index
[OR 182.2(95% 2.2-150.7), p¼0.021] were found to be the indepen-
dent factors predicting MS.
Conclusion: Metabolic Syndrome was highly prevalent (77%) in
our patient population. Patients with MS were significantly older,
had significantly higher lipid values, higher BMI, WHR, waist
height ratio and conicity index but lower GFR. Dietary intake was
statistically similar in both the groups. BMI (>23), GFR (<60) and
conicity index were the significant factors predicting MS.Risk stratification after STEMI with fragmented
QRS e A simple EKG marker
Katyal, Mahajan, Gupta T.
Post Graduate Institute of Medical Sciences, Rohtak, Haryana
Fragmented QRS complexes (fQRSs), which include various
RSR’ patterns, without a typical bundle-branch block aremarkers of altered ventricular depolarization owing to a prior
myocardial scar. Presence of fQRS might be associated with a
poorer outcome in patients of acute STEMI. 214 consecutive
patients of acute ST Elevation Myocardial Infarction (STEMI)
were studied to delineate impact of fQRS on outcome after
AMI. Fragmented QRS developed in 139 patients out of 214
(64.9% ¼ GROUP A) during the hospital stay. 75 patients did not
develop fragmented QRS during the hospital stay (35.04% ¼
GROUP B). In comparison Q wave which appeared in 137 pa-
tients (64.01%), 77 (35.9%) patients who did not develop a Q
wave on ECG post MI, fragmented QRS developed in 57 of them
(26.6%), thus making it a valuable tool in identifying a Q wave
MI. Fragmentation of QRS developed within first 48 hours of
STEMI in 97% patients and was most commonly seen in inferior
leads (76.2%). Demographic data was comparable in two
groups. Cardiac markers CK MB and Troponin-I levels were
significantly higher in group A patients (p<0.01) indicating
increased magnitude of myocardial necrosis associated with
fragmentation QRS. Increased rates of post MI angina,
congestive heart failure, and major tachyarrhythmias were
observed upto 30 days of follow up in patients of group A as
compared to group B patients (p<0.01). This study of 214 STEMI
patients highlighted the usefulness of fragmented QRS in
identifying patients at higher risk of MAACE with larger
cumulated areas of ischemic jeopardized or necrotic myocar-
dium, and it can provide very useful information in the risk
stratification of such patients. It also helps to identify the ev-
idence of infarction in patients without a Q wave on surface
ECG.Improvement in exercise capacity is
independent of ejection fraction in patients with
coronary artery disease (CAD)
Rajeev Gupta
Gandhi Medical College, Bhopal & Associated Hospital, Bhopal, Madhya
Pradesh
Aims and objective:A low ejection fraction (EF<35%) is considered
high risk for cardiac events. It is believed that these patients
should not undertake intense physical activity. The present study
was aimed to determine safety and efficacy of exercise training in
CAD with low EF and to evaluate whether outcomes differ in pa-
tients with normal or reduced EF.
Methods: 125 patient with CHD were prospectively analyzed,
based on the EF after coronary event patients were divided in to
three groups: normal EF (55%- 77%-70patients), moderately
reduced EF (35%-54%: 30 patients) and low EF (<35%: 25 patients).
Exercise capacity was determined based on history of physical
activity undertaken. Exercise was prescribed at 60% -80% of pre-
dicted maximum heart rate.
Results: Physical activity significantly improved exercise
endurance. On comparing the % change in the distance covered
and exercise level and activities undertaken no significant dif-
ference (p¼0.694) was found between the 3 groups, indicating
that improvement in the exercise capacity is independent of
the EF.
Conclusion: Low EF patients with CHD can safely participate in
symptom monitored and medically supervised physical activity,
and experience significant gains in exercise capacity equivalent to
those with normal EF monitored by symptoms arrthymias and EF.
Keywords: Exercise capacity, Ejection fraction.
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) S 1eS 3 2 S5Differential release kinetics of cardiac
biomarkers in patients undergoing off pump
coronary artery bypass surgery
Satyajeet Singh, Aditya Kapoor, S. K. Agarwal, Shantanu Pande,
Archana Sinha, Himanshu Rai, Sudeep Kumar, Satyendra Tiwari,
Naveen Garg, Gauranga Majumdar, Bipin chandra, P. K. Goel
Sanjay Gandhi PGIMS, Lucknow, Uttar Pradesh
Background: B-type natriuretic peptide (BNP) is a routinely used
biomarker for heart failure. Levels of BNP increase in patients
undergoing open heart surgery. Advent of off pump CABG
(OPCABG) has reduced peri-operative morbidity and mortality.
Methods: We prospectively studied release kinetics of BNP,
Troponin-I (TnI) and CKMB 24 hours prior, and 6,24,48 hours and 1
month after OPCABG in 80 patients. (mean age 59.1 yrs, LVEF
52.4%,83% males).
Results: Baseline BNP, TnI and CKMB levels were 105.8 pg/ml, 0.9
ng/ml and 2.34 ng/ml. Although all biomarkers increased signifi-
cantly within 6 hours of surgery, release kinetics were different.
While peak BNP levels occurred in 96% patients by 24-48 hours, for
TnI and CKMB, this was observed in only two-thirds. A trend to-
wards fall in all biomarkers was seen by 48 hours; while TnI and
CKMB levels normalized in all at 1 month, 42% patients still had
BNP > 100 pg/ml. Those with baseline BNP > 100 pg/ml had lower
LVEF (43.6vs55.6%, p<0.01), longer inotrope duration (43.8vs31.4
hrs, p¼0.03) and ventilator support time (33.9vs25.6 hrs, p¼0.04);
mean ICU and hospital stay were similar to those with lower BNP.
Despite baseline BNP differences, levels of TnI and CKMB at all
times were similar in these two groups. BNP levels had positive
correlation with patient age and angiographic Syntax score
(p¼0.02) and negative correlation with LVEF. Of all biomarkers,
only baseline BNP predicted inotrope duration (OR4.9, 95%CI:1.3-
17.7, p¼.01) and ventilation time (OR4.5,95%CI:1.2-16.6, p¼.02).
Post-operative levels of BNP at 6,24 and 48 hours and delta BNP
were significant predictors of mean ventilation time only.
Conclusion: Even in patients undergoing OPCABG, there is sig-
nificant natriuretic peptide (BNP) and myocardial enzyme release
(TnI, CKMB) notable within 6 hours of surgery. Patients with
higher baseline BNP levels had longer inotrope and ventilator
duration. Of all the biomarkers, only BNP had an association with
post-operative variables.Aspirin and clopidogrel resistance and their
genetic association in Indian patients with
coronary artery disease
Mahajan Parag Vijay, Sawhney J. P. S, Mohanty Arun,
Arya Vandana, Bhargava Manorama, Sarf Amirita
Sir Ganga Ram Hospital, Delhi
Introduction: Combination therapy with clopidogrel and low
dose aspirin is the current standard of care in the management
of patients with Coronary Artery Disease (CAD) including acute
coronary syndromes (ACS). Between 4-30% of patients treated
with conventional doses of clopidogrel show an inadequate
platelet response. This may partly be done to underlying ge-
netic diversity among individuals. Platelet resistance to aspirin
is reported to affect <1% of patients as tested by light trans-
mission aggregometry (LTA). To the best of our knowledge, no
studies are available in the Indian population of geneticpolymorphisms which may affect platelet response by these
antiplatelet agents.
Methods: A total of 65 patients with CAD/ACS who were stable on
dual anti platelet therapy (Clopidogrel 75 mg OD and aspirin 150
mg OD), were investigated along with age and sex matched 65
controls. Demographic and clinical data was collected on a pre-
designed clinical proforma. Platelet function testing by light
transmission aggregometry was done with 4 agonists (ADP 2mM
and 10mM, Epinephrine 5mM, Collagen 2mg/ml, Arachidonic Acid
0.75mM) in each patient/control. After meta analysis the criteria
employed for the Aspirin resistance was mean platelet aggrega-
tion 70% with 10mM ADP and 20% with 0.75mM of Arachidonic
acid. Aspirin semi responders were defined as those meeting only
one of the above criteria. Clopidogrel resistance was defined as
<10% decrease from the baseline in platelet aggregation in
response to ADP 2 & 10mM.Semi responders were defined as 10-
29% (<30%) decrease from the baseline. A baseline mean platelet
aggregation obtained from 28 controls. Polymorphisms
CYP2C19*2, CYP2C*3, CYP3A5*3 and PLA1/A2 were genotyped by
PCR-RFLP.
Results: ADP induced aggregation was highly variable among
patients. While clopidogrel resistance was observed in 1(1.5%)
patient, 27(41.5%) patients were semi responders to clopidogrel.
4(6.15%) patients were semi responders but none were resistant to
aspirin. All 4(6.15%) were semi responders to clopidogrel also. Poor
responders had higher frequency of the *2 Allele of CYP2C19
(p¼0.026) & *3 Allele of CYP3A5 (p¼0.022) as compared to re-
sponders. PLA1 was also found to be significantly higher in
platelet hypo responders (p¼0.045). None of the patients were
found to have mutant genotype of CYP2C19*3. Statistically sig-
nificant correlation was not found in responders and semi & non
responders in relation to angina class, diabetes, hypertension,
type of intervention including drug eluting stents, different statins
and PPI.
Conclusion: There was significantly higher frequency of *2 allele
of CYP2C19, *3 allele of CYP3A5 and PLA1 in clopidogrel semi re-
sponders as compared to responders. But no clinical parameter,
type of intervention and drugs affected response to aspirin and
clopidogrel. These preliminary findings suggest that poly-
morphisms may be associated with inadequate response to anti-
platelet drugs.Prevalence of coronary atherosclerosis e An
autopsy study in a tertiary care centre in South
India
Sandeep G. Nair, Sunitha Viswanathan, Sarath Kumar, P. Rema,
Kiran Gopinath
Government Medical College and Hospital, Thiruvananthapuram, Kerala
Background: Coronary atherosclerosis is the leading cause of
morbidity and mortality in the industrial world. However, data on
the actual population burden of atherosclerosis is lacking. Au-
topsy studies may be an effective method of identifying popula-
tion trends in coronary atherosclerosis.
Aims and objectives: To study the autopsy prevalence of signifi-
cant coronary atherosclerosis in an unselected group of medico-
legal autopsies.
Methods: Cross sectional study conducted on 300 consecutive
autopsies conducted in our institution from February 2013 to April
2013. The heart specimens were weighed and gross morphology
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) S 1eS 3 2S6studied. Serial sections (3mm apart) of coronary arteries were
examined for gross atherosclerosis. In the first 100 specimens,
macroscopic atherosclerotic lesions were biopsied and graded by
histopathology and in the absence of any specific macroscopic
lesions, sections from each of the coronary artery segments were
examined.
Results: The mean age group was 46.28  18 yrs and females
accounted for 22%(68/300) of the population studied. Sudden
cardiac death as the event leading to death was identified in 6.3%
(19/300) of the study population. Female gender was associated
with a significantly lower mean weight of the gross specimen and
significantly lower ostial diameter of coronary arteries. RVEMF
was identified in 1% (3/300) indicating higher prevalence of the
disease in this part of the country.
By visual assessment, significant atherosclerotic luminal ste-
nosis (defined as 50% area stenosis in Left Main coronary artery
(LMCA) & 75% area stenosis in other vessels) was identified in 68
(22.6%) of cases. Out of these, isolated significant LMCA disease
was found in 7 (2.3%) of cases, LMCA þ single vessel disease (SVD)
was found in 5 (1.7%) cases, LMCAþ two vessel disease (2VD) was
found in 4 (1.3%) of the cases and LMCAþthree vessel disease
(3VD) was found in 1(0.3%) case, SVD in 37 (12.3%) cases and 2VD
in 14 (4.7%) cases.
Histopathology revealed significant atheroma ( Grade 4) in 61%
of cases, of which, isolated significant LMCA disease was found in
3%, LMCAþ SVD- 8% cases, LMCA þ 2VD - 9% of the cases,
LMCAþ3VD- 4% of the cases, SVD- 14% cases, 2VD in 16% cases
and 3VD in 7% of cases.
Visual assessment of coronary arteries was 85% sensitive and
91.25% specific for identification of significant atherosclerosis as
compared to histopathology, which is the gold standard. However,
histopathological assessment of the aorta resulted in the pick up
of 20 more cases of significant grade of atherosclerosis(  grade4)
which would have been regarded as insignificant by visual
assessmentda 20% higher pick up rate.
Conclusions: Although the cardiac cause of death could be iden-
tified only in 6.3% cases, significant coronary atherosclerosis was
identified in 22% of gross specimens and 61% of histopathology
specimens, highlighting the high prevalence of significant,
asymptomatic coronary atherosclerotic disease in the population.
Though visual assessment had good sensitivity and specificity in
detection of significant coronary atherosclerosis, histopathology
had an edge in case of aortic atherosclerosis.Adiponectin, central obesity, carotid intima
media thickness and coronary artery disease
Amitesh Aggarwal, Rajesh Jain, Shridhar Dwivedi
University College of Medical Sciences & GTB Hospital, Delhi
Background: Atherosclerosis related coronary artery disease has
emerged as a principal cause of death all over the world. One of
the clinical syndromeswhich often lead to coronary artery disease
(CAD) is metabolic syndrome. Adiponectin is diminished both in
metabolic syndrome and CAD. Carotid intima media thickness
(CIMT), a surrogate marker of subclinical atherosclerosis has been
found to be increased in CAD and has inverse relationship with
adiponectin. In view of the paucity of Indian studies available
addressing the interrelationship between adiponectin, waist
circumference, CAD and CIMT; we aimed to examine the inter-
relationship between adiponectin, central obesity and CIMT in
patients suffering from CAD.Methods: We studied the levels of adiponectin, measured CIMT
and obesity profile of CAD patients (n¼50)60yrs admitted in CCU
of GTB Hospital and compared it with apparently healthy controls
(n¼50). Increased waist circumference, considered as central
obesity was defined as WC 90 cm in males, 80 cm in females
and obesity was considered as Body Mass Index 25 kg/m2.
Results: The mean age in CAD cases (43.78.2yrs) and controls
(43.69.2yrs) were similar. Smoking was found in 36 (72%) of CAD
cases and 23 (46%) of control subjects. Increased waist circum-
ference was found in 24 (48%) of CAD cases and 12 (24%) of
control subjects. Raised BMI was found in 42% cases as compared
to 22% in healthy controls. Mean adiponectin levels in CAD pa-
tients was 8.143.86 mg/ml as compared to 9.43.9 mg/ml in
healthy controls. Values though higher in CAD group was sta-
tistically insignificant. Mean CIMT was higher in CAD cases as
compared to healthy controls (0.680.10 mm vs 0.600.11mm).
The mean adiponectin levels were higher in non-obese as
compared to obese individuals (9.2 vs 6.9 mg/ml) and those
without central obesity as compared to those with central
obesity (9.3 vs 7.2 mg/ml) in CAD patients. Adiponectin had a
negative correlation with CIMT in CAD patients [Pearson’s cor-
relation ¼ -0.198 (p¼0.220)].
Conclusion: Our findings indicate evidence of low adiponectin,
increased CIMT and increased prevalence of central obesity in
CAD patients as compared to healthy controls.Correlation between plasma 25-OH-D level with
angiographic finding in male STEMI patient
Priyadarsi Tripathy, Trinath mishra, K.K. Goel, B. Chug, B. Jena
S.C.B. Medical College, Cuttack
Background: Growing evidence has suggested that low blood
levels of 25-OH vitamin D are associated with higher risk of
developing coronary heart disease. Because hypovitaminosis D is
prevalent and easily correctable, establishing the relationship
between vit D and risk of MI is important.
Aims and objective: To evaluate serum 25-OH eD level in male
patient with STEMI and to correlate with severity of angiographic
findings.
Method: A nested case-control study was conducted in the
department of Cardiology SCBMCH taking 120Male STEMI patient
aged 40 to 75 years. Blood sample collected after admission and
correlated with severity of Angiographic finding.
Result: After adjustment for matched variables, mean serum 25-
OH D level was 32.47 4.35 ng/ml in control vs 14.034 5.39 ng/ml
in study group (p value < 0.0001). Among 83 patients 21.7% having
SVD (Single vessel disease) with mean 25-OH-D level was 21.62 
2.34 ng/ml, 36.1% having DVD (double vessel disease) with mean
level was 14.6 2.10 ng/ml; 42.2% having TVDwithmean 25-OH-D
level found 9.66  3.60 ng/ml. Lower level of 25-OH-D leads to
increased severity of angiographic findings. Findings are more
specific in older patients. Patients with lower vitamin d level
having more trend towards complications like heart failure,
arrhythmia, periprocedural AMI etc.
Conclusion: This study analysis regarding the level of vit D and its
correlation with severity in angiogram in male patient with
STEMI. Low levels of 25-OH-Dmight be one of the etiological factor
and prognostic marker associated with higher risk of myocardial
infarction in a graded manner, even after controlling for factors
known to be associated with coronary artery disease.
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beta-defensin and histatin-3 for risk assessment
for recurrent coronary artery disease
Sapna Singh, S. K. Gupta, Alpana Saxena, Rashid Mir, Sameer
Ahmed
Maulana Azad Medical College, New Delhi
Background: It is well understood that premature coronary artery
disease (CAD) occurs more frequently in Indian population in
comparison to other ethnic groups. Several studies including our
recent findings have suggested that pathogen burden specifically
Cytomegalovirus (CMV) infection in combination with inflam-
matory markers show significant association with CAD and
recurrent CAD in Indians. Further global proteome analysis may
give more biomarkers for better risk assessment for these events.
Objectives: This study was aimed at identifying new biomarkers
by performing comparative global proteome analysis for
improvement of risk assessment of recurrent CAD.
Methods: 170 age and gender matched subjects (85 CAD affected
and 85 recurrent CAD) were selected for this study from ongoing
Indian Atherosclerosis Research Study (IARS) as published earlier.
All the blood samples were collected after overnight fasting of 12-
14 hours and stored at -80C. Global proteomic analysis was per-
formed using Surface Enhanced Laser Desorption/Ionization
CM10 arrays on serum samples of these subjects and Tagident
software for protein identification which were validated using
western blot followed by ELISA assays. Logistic regression, haz-
ards ratio, C-statistics, Keplan Meier curve analysis, multi-marker
risk score and net reclassification index were performed using
SPSS Version 17 software and R-package.
Results: We have identified 39 protein peaks differentially
expressed of which 19 were significantly differentially expressed
in CAD affected versus recurrent subjects. Of these 19 peaks, two
peaks corresponding to m/z 8588 and 1864 identified as beta-
defensin-128 and histatin-3 were significantly associated with
recurrent CAD with odds ratios of 7.49 (95%CI 2.57-21.90, p-value
<0.001) and 1.4 (95%CI 1.02-2.13, p-value¼0.042) respectively.
Further analysis shows higher levels of these biomarkers in serum
of recurrent event subjects compared to affected subjects. Use of
these biomarkers in the risk assessment was evaluated by haz-
ards ratio analysis where combination of biomarkers with con-
ventional risk factors had a hazards ratio of 1.833 (95%CI 1.34-2.50,
p-value¼1.30x10-4) which served as the final model for risk
assessment. Multi-marker risk score of the combined model
Conclusions:We have identified two potential biomarkers for risk
assessment for recurrent CAD namely beta-defensin-128 and
histatin-3. Further validation of these biomarkers in larger cohort
may help in improvement of risk stratification for recurrent CAD
subjects.Global urinary proteome analysis for biomarker
discovery for coronary artery disease risk
prediction in Asian Indians
Sapna Singh, S. K. Gupta, Alpana Saxena, Rashid Mir, Sameer
Ahmed
Maulana Azad Medical College, New Delhi
Background: Diagnosis of premature coronary artery disease
(CAD) is a major concern and several studies have focused on
using the urinary proteome approach due to non-invasive biofluidcollection, low complexity and stability of proteins. These studies
are more important in Indian population where premature CAD is
increasing at alarming rate.
Aim: In this study we have analyzed global proteomic profile
analysis of urinary proteome of Asian Indians to identify
biomarker profile for premature CAD risk prediction.
Methods: 407 age and gendermatched subjects were selected for a
case control study from ongoing Indian Atherosclerosis Research
Study (IARS) (Indian Heart J, 2010;6:286-95) which was designed
according to the guidelines of World Medical Association Decla-
ration of Helsinki and Indian Council of Medical Research and
approved by Institutional Ethics Committee. Patients living in
India for at least two generations were enrolled after signed
informed consent was obtained (male60 years and female63
years at onset of disease, diagnosed as CAD without any major
diseases like cancer or liver failure). All the urine samples were
collected after overnight fasting of 12-14 hours and stored at
-80oC. Global proteomic analysis of urine samples were per-
formed using Surface Enhanced Laser Desorption/Ionization-
Time of Flight (SELDI-TOF) on three different arrays cationic
CM10 (204 CAD affected and 203 unaffected), anionic Q10 (80 CAD
affected and 79 unaffected) and metal binding IMAC30 (196 CAD
affected and 195 unaffected) chips. For risk prediction model
development, we used four different statistical methods namely
Support Vector Machine (SVM), Multilayer perception Artificial
Neural Network (ANN), Discrimination Analysis (DA) and Logistic
Regression (LR).
Results: 118 significantly differently expressed protein profiles
were identified from SELDI-TOF analysis in all the arrays. The
CM10 array gave 55 peaks, 29 peaks in Q10 and 34 in IMAC array
chips. Four different statistical analyses (SVM, ANN, DA and LR)
were performed for developing risk assessment algorithm for
each array type. In each of the statistical methods half of the
samples were used for validation in a blind test. In all the array
types, SVM based algorithm gave the significant risk assessment.
In CM10 array the SVM based risk stratification had sensitivity of
91.22%, specificity of 67.13%, AUC of 0.961, Q10 array sensitivity of
82.93%, specificity of 79.22%, AUC of 0.921 and IMAC: sensitivity
of 78.76%, specificity of 80.30%, AUC of 0.878. Furthermore, we
identified that five protein peaks corresponding to myotropin,
prepronociceptin, StAR-related lipid transfer protein 5, D-amino
acid oxidase activator, and integral membrane protein 2C as sig-
nificant proteins in the above SVM based model for risk
assessment.
Conclusions: Our data suggests that urinary proteome profile can
be used to identify new biomarkers which may be related to pre-
mature CAD in Asian Indians. Further studies of integrating the
genomic data (gene expression and single nucleotide poly-
morphism) using bioinformatics tools are underway for devel-
oping systems biology based risk assessment.Protein-protein interaction network topology
based multimarker identification for coronary
artery disease
Sapna Singh, S. K. Gupta, Alpana Saxena, Rashid Mir, Sameer
Ahmed
Maulana Azad Medical College, New Delhi
Background: Cardiovascular disease is a complex disease result-
ing from combinatorial affect of environmental, genetic and life
style factors. Multimarker based risk prediction methods are
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provide required clinical interventions to prevent the disease
from occurring. Many methods depend only on statistical signif-
icance of based association of biomarkers to the disease and less
of biological functions or networks of the proteins playing
important role in the disease. Herein, we explored protein-protein
interaction (PPI) network topology based identification of core
biomarkers whichmight of use formultimarker risk prediction for
coronary artery disease.
Methods: We downloaded all the genes listed in the CAD GENE
database version 1 and constructed protein-protein interaction
network using STRING database which was further analyzed in
Cytoscape (version 2.8.3) followed by functional enrichment using
Cluepedia. 500 patient serum samples were used to validate
selected biomarkers from Indian Atherosclerosis study. SPSS
version 17 software was used to perform the statistical analysis.
Results: Using the two centrality measures, node degree distri-
bution and betweenness centrality for all 318 seed proteins IL6
was observed as the hub protein following power of law distri-
bution with an r2 value of 0.614. Out of all the nodes of the PPI
network 15 proteins were found as backbone proteins which after
extending the network give 346 proteins consisting of all the
proteins included in the network. The functional enrichment
using significant Gene Ontology terms (p-value <0.01 after
Benjamini-Hochberg correction) gave a 30 important GO terms.
Further, we validated 2 biomarkers IL6 and hsCRP to be associated
with CAD.
Conclusion: The network of biomarkers from 318 CAD gene
database have yielded a important lead of backbone biomarkers
from different pathways correlating to risk of CAD.Integration of genomic and proteomic
approaches to understand the transcriptional
regulatory program in coronary artery disease
Rajani Kanth Vangala, Madankumar V. G., Madhavan O.,
Jayashree S., Vijay V. Kakkar
Thrombosis Research Institute, Bangalore, Karnataka
Background: Patients with coronary artery disease (CAD) show a
panel of differentially regulated serum biomarkers indicative of
modulation of several pathways from disease onset to progres-
sion. Some of these biomarkers have been proposed for multi-
marker risk prediction methods. The underlying mechanism of
the expression changes and modulation of the pathways in risk
assessment needs to be addressed.
Aim: Our present work focuses on understanding the regulatory
mechanisms at transcriptional level by identifying the core and
specific transcription factors that regulate the CAD associated
pathways.
Methods: Using the principles of systems biology we integrated
the genomics (gene expression data of 10 CAD affected and 10
unaffected) and proteomics (400 affected and 400 unaffected) data
with computational tools. The two sets of samples for gene
expression and proteome analysis were selected from ongoing
Indian Atherosclerosis Research Study (IARS) (Indian Heart J,
2010;6:286-95) which was designed according to the guidelines of
World Medical Association Declaration of Helsinki and Indian
Council of Medical Research and approved by Institutional Ethics
Committee. Patients living in India for at least two generations
were enrolled after signed informed consent was obtained
(male60 years and female63 years at onset of disease,diagnosed as CAD) and all the blood samples were collected after
overnight fasting of 12-14 hours and stored at -80oC. We selected
biomarkers from 7 different pathways based on their association
with the disease and assayed 30 biomarkers by ELISA and built
network modules using STRING database. The biomarkers
selected were inflammation: Interleukin-6, Interleukin-8,
Interleukin-10, Interleukin-12A, Interleukin-12B, Interleukin-18,
Monocyte chemoattractant protein-1, High sensitive C reactive
protein, Interferon gamma, Matrix metalloprotease-9 and secre-
tary Phospholipase A2 and Gamma-glutamyltransferase-5, coag-
ulation: Factor VII, Fibrinogen, Prothrombin, Plasminogen
activator inhibitor-1, Plasminogen, Tissue factor, von Willebrand
Factor, Platelet derived growth factor, cell adhesion: Clusterin and
P-selectin, obesity: Adiponectin and Leptin, oxidative stress:
Myeloperoxidase, stress: HSP27, HSP60, HSP70 and renal function:
Cystatin C. The promoter sequence analysis for transcription
factor binding sites was performed using Genomatrix software
and microarray data was analyzed using R package v2.14.2.
Results: The Genomatrix software predicted 443 transcription
factors binding profile in 30 different biomarkers, however, in
global mRNA expression only 34 transcription factors were found
to be differentially expressed in CAD affected and unaffected
subjects. Out of these 5 transcription factors binding sites were
highly represented in the promoter sequences of all 30 biomarkers
thus forming the core regulatory transcription machinery which
might influence the differential levels of biomarkers in serum of
CAD affected subjects in comparison to unaffected. The 5 core
transcription factors were PPARG, EGR1, ETV1, KLF7 and ESRRA
and their combinatorial regulation may influence all the 7
important pathways associated with CAD as outlined above.
Conclusions: Our analysis suggests that a profile of 5 core tran-
scription factors binding to the promotersmay play amajor role in
differential levels of biomarkers associatedwith CAD and thus use
of this profile of transcription factors may be useful to identify
new biomarkers which may play a role in risk assessment in CAD.Association between the Glu298Asp
polymorphism of endothelial nitric oxide
synthase and coronary slow flow in the North
Indian population
Ashish Govil, Sanjay Tyagi, Sumod Kurian, Mohit Gupta, Sandeep
Golcha, Girish M. P., Amit Mittal, Partha P. Choudhary
GB Pant Hospital, Maulana Azad Medical College, and Institute of Ge-
nomics and Integrative Biology, Mall Road, Delhi
Background: Genetic variants in endothelial nitric oxide synthase
(NOS3 gene) leading to endothelial dysfunction may be predis-
posing to coronary slow flow phenomenon (CSFP).
Objective: To study the role of NOS3 Glu298Asp polymorphism
and NO levels in a subset of North Indian patients with coronary
slow flow phenomenon
Methods and results: In this study, we examined the relationship
between Glu298Asp (894G/T) polymorphism of NOS3 and CSFP. A
total of 27 patients with CSFP but otherwise normal coronary ar-
teries (mean age 50.48.2 years) and 200 controls with normal
coronary angiogram (mean age 50.39.3 years) were screened for
Glu298Asp polymorphism by restriction fragment length poly-
morphism. Nitric oxide levels were determined by Griess’ enzy-
matic method for an association with the polymorphisms. The
genotype distribution of the Glu298Asp polymorphism differed
significantly between the CSFP patients and controls (P<0.05). The
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prevalent in patients in comparison to controls (P¼0.001) and T
allele was significantly prevalent in patients (P¼0.001). Nitric oxide
level was higher in patients than in controls, the values being
144.7550.84 mM and 131.0059.6 mM, respectively (P¼0.055). The
genotypes showed a trend of association with NO levels, which
decreased linearly in the order of GG>GT>TT (P >0.05).
Conclusions: The Glu298Asp polymorphism of NOS3 may be a
responsible for CSFP.Interventional CardiologyRare cause of cyanosis-abernathy malformation
and park malformation
B. Amirtha Ganesh, Ravi Cherian Mathew
Mahatma Gandhi Medical College and Research Institute, Pondicherry
We present a 9 year old girl who presented to our outpatient
department with cyanosis and clubbing with dyspnoea NYHA
class II of 8 months duration. Patient had Ostium secundum ASD
for which she underwent surgical closure 3 years back. Clinical
examination was unremarkable except for cyanosis and clubbing.
Her resting oxygen saturation was 84%. ECHO revealed normal
pulmonary venous drainage, intact IAS and normal biventricular
function and pulmonary arterial pressure. Contrast ECHO with
agitated saline revealed the appearance of dense contrast in the
left atrium and ventricle after 3 to 4 cycles after appearing in right
ventricle which is diagnostic of pulmonary A-V communication
with 100% specificity. The gold standard 320 sliced CT angio done
elsewhere was reported normal.
With ECHO finding which was very characteristic of pulmonary
A-V communication we proceeded with pulmonary angiogram
which was suggestive of bilateral diffuse pulmonary A-V
communication. The USG abdomenwas normal except for a small
hyperechoeic lesion in the spleen suggestive of hemangioma. The
clinical profile at this juncture was suggestive of osler-rendu-
weber disease where diffuse pulmonary A-V malformation is a
part of the disease along with hemangiomas in other parts of the
body. Hence it was decided to screen other areas of the body
especially the brain to identify and treat any A-V malformation in
the brain so that a major catastrophe can be prevented.
Repeat USG done was suggestive of Phelebolith in the Spleen
rather than Hemangioma. MRI Brain was done showed changes
that are usually seen in hepatic failure. Normally, ammonia and
other vasodilators from portal circulation gets detoxified in the
liver before reaching systemic circulation. In hepatic failure this
step is bypassed hence reaches various parts of the body pro-
ducing some typical pathological changes. But with normal liver
function in this child why should these changes occur?
Thesefindings arouse the suspicionof a communication reaching
systemic circulation bypassing liver. Repeat ultrasound abdomen
revealed large left branch of portal vein reaching IVC-RA junction
bypassing liver. This could also explain diffuse pulmonary A-V
communication producing cyanosis.64 slice CT whole abdomen
was donewhich revealed a Large posterior division of the left portal
vein draining into the IVCeAtrial junction (Abernathy Type II) with
a small tortuous venous channel from branch of the left portal vein
draining into left hepatic vein (Park Type II). Inferior Vena cava and
selective angiogram of the communicating portal vein done,
confirmed the CT findings.Embolization of the Abernathy malformation was done using
amplatzer vascular plug-II and coil embolization of the park
malformation done.
Follow up after 3 weeks revealed complete absence of cyanosis,
resting saturation of 97% and normal contrast ECHO.
This is one of the rarest cause of cyanosis.
This case is unique for the following reasons.
Gold standard 320 sliced CT was not able to identify the diffuse
pulmonary A-V communication though contrast ECHO was
characteristic.
Both Abernathy and park malformation in the same patient.
Co-existed with ASD but presented late after ASD closure.
Symptomatic relief after embolization.
With all above unique features this is the first of its kind to be
reported in the literature.5 years clinical follow up results of Genous
bioengineered stent in acute coronary syndrome
in Indian patients
T. Ghose, U. Kaul, R. Kachru, R. Gupta, S. Sayal, A. Hussain,
A. Shiraz I
Fortis Flt. Lt. Rajan Dhall Hospital, New Delhi
Background: Endothelial progenitor cell capturing stents (EPCS)
are coated with CD4 antibodies targeting endothelial progenitor
cells and thus help in early healing & likely to prevent early and
late stent thrombosis. Impact of EPCS in the real world scenario
on the prevention of late stent thrombosis is not known. We
assessed the long term (>5 years) clinical outcome of EPCS
implanted for the treatment of acute coronary syndrome (ACS) in
our cohort.
Methods: 22 unselected patients admitted with ACS between May
2006 and March 2007 with ACS were treated with 24 EPCS. All
patients received dual antiplatelet therapy upto 1 year followed by
Aspirin indefinitely. All patients also received Atorvastatin 80 mg
following the procedure and continued as per standard protocol.
All these patients were followed up upto more than 5 years & long
term thereafter.
Results: 22 patients were treated with 24 stents. Out of 11 ST
elevation MI (STEMI) one patient received 2 overlapping stents.
Rest of the patients had Non STEMI/ACS. Of these, one patient had
received 2 non study overlapping bare metal stent along with 2
EPCS in the RCA because of long dissection. One patient had pla-
que prolapse during the procedure. One patient with cardiogenic
shock (CS) died after 12 hours. Angiographic follow up at 8months
done on 10 STEMI patients showed reference vessel diameter
mean/SD 2.94þ0.29 post procedure, 2.64þ0.57 at 8 months, post
procedure MLD 2.52þ0.35mm & 1.53 þ 1.01 at 8 months, post
procedure diameter stenosis 11.7 þ 5.59% & 45.2þ30.2% at 8
months, binary stenosis in 5(50%), late loss of 0.97þ0.94 mm and
late loss index of 44.35 þ 40.47. Complete clinical data was avail-
able in 15 (68.18%) patients upto mean follow up of 83.42 months.
There was 1 death due CS, one total occlusion and one repeat
PTCA using cutting balloon.
Conclusions: Genous  bioengineered stent implantation in acute
coronary syndrome was safe at short term and associated with
high late loss during angiographic follow up at 8 months. Inspite
of these features, late stent thrombosis and very late stent
thrombosis was not seen during long term follow-up of 83.42
months duration.
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octogenarians
T.Ghose,R.Kachru, R.Gupta, S. Sayal,A.Hussain, R. Sud,AShiraz I,
A. Mishra, U. Kaul
Fortis Flt. Lt. Rajan Dhall Hospital, New Delhi
Background: Elderly people of age group > 80 years were excluded
from randomized controlled trials of primary percutaneous cor-
onary intervention (PPCI) in ST elevation myocardial infarction
(STEMI) studies. There is paucity of outcome data of PPCI in
octogenarian from this part of the world. We herein report the
inhospital and thirty days outcome data of transradial PPCI in
patients of STEMI and aged > 80 years.
Methods: In this retrospective study, all the patients of acute
STEMI in the age group of > 80 years who underwent PPCI for
STEMI through transradial route were identified. In hospital re-
cords were reviewed. Telephonic contacts with all the patients
were made for confirmation of 30 days outcome.
Results: 14 octogenarians underwent PPCI for STEMI between
February 2011 and June 2013. 2 patients underwent transfemoral
PCI. Complete data was available in remaining 12 patients.
Mean age was 84.5 þ 15.6 (80-92 years). Majority were males e 8
(66%). Hypertension e 11 (91.6%), dyslipidemia e 8 (66%), dia-
betes mellitus e 3 (25%), family history of coronary artery dis-
ease - 3 (25%) and smoking e 2 (16%) were the risk factors
present in the cohort. The median door to balloon time was 38
mins. 8 patients received 2nd generation drug eluting stent and
remaining were treated with bare metal stents. The mean left
ventricular ejection fraction were 32.5 þ 18.5%. 4 patients had in
hospital congestive heart failure. There was no death, recurrent
MI, revascularization and rehospitalisation in these patients up
to 30 days follow up.
Conclusions:We conclude that transradial primary angioplasty is
associated with good in hospital and shortness outcome in the
octogenarians. Retrospective nature, single centre data and small
sample size are the limitations of our study.Primary angioplasty for young adults (less
than 35 years of age) with acute myocardial
infarction - Clinical profile and outcome
Krupal Reddy, P. C. Rath, Md Abdul Azeez Asad, Manoj K.
Agarwala, Bharat V. Purohit, T. Badrinarayana, Tripti Deb,
Byomakesh Dikshit
Apollo Hospital, Jubilee Hills, Hyderabad, Andhra Pradesh
Background: Indians develop acute myocardial infarction (AMI)
about 10 years earlier than western population. In addition, these
young patients have different risk factor profile, clinical presen-
tation and prognosis than older patients.
Aims and objectives of the study: To identify the demographic,
clinical and angiographic profile of young (<35 years) Indian pa-
tients with AMI undergoing primary angioplasty and to assess in-
hospital and intermediate outcomes following PCI.
Materials and methods: The study was carried out at Apollo
Health city, Jubilee Hills Hyderabad from January 2003e June 2012.
Of consecutive 780 patients who underwent primary angioplasty,
102 young patients (<35 years) were enrolled in the study.
Randomly selected 102 patients of > 35 years were enrolled as
controls. Patient demographic and risk factors were studied. The
following clinical outcomes were analyzed e death, myocardialinfarction, target lesion revascularization during hospital stay and
during the follow up of 1 year after discharge from index hospi-
talization. Primary PCI was performed on to infarct related artery
only. Use of GPIIb/IIIa receptor antagonist, thrombosuction device
was as per the discretion of the operator.
Results: In our study, all the young patients were male (100% &
69%, p<0.001). The mean age in young group was 30  5 years, in
old age group was 50  15 years. Among risk factors, diabetes
mellitus (10.7% & 48%, p < 0.001) and hypertension (14.7% &
50.9%, p<0.001) were more common in older patients. Family
history of CAD (44.1% & 10.7%, p<0.001), was more in young
patients. Most of young patients were from urban areas (84.3% &
58.8%, p<0.001) and were working in corporate sector (85.2% &
50.9%, p<0.001). The young patients were more likely to present
with chest pain (91.1% & 86.2%) and less likely to have heart
failure (20.5% & 24.5%) (p¼NS). The mean cholesterol level was
18836.6mg/dl vs 20632.4mg/dl, the mean LDL level
13032.6mg/dl vs 142 31.8mg/dl, the mean HDL level
358.1mg/dl vs 34 7.8mg/dl, the mean triglyceride
level 18078.3mg/dl vs 19265.3mg/dl (p¼NS). On coronary
angiography, single vessel disease was seen in 82.3% (n¼84) in
young age group vs 53.9% (n¼55) (p < 0.05) patients in control. In
hospital, four patients died in young group whereas eight pa-
tients died in older age group (p ¼ 0.37). Three patients each
from both groups had stent thrombosis requiring repeat PCI
during hospital stay (p¼NS). On long term follow up for one
year, 8.3 % patients from young age group required a repeat PCI
as compared to 17.4 % in older age group. Five patients in young
age group developed repeat MI as compared to eleven in control
group. Overall mortality at one year was 1.96 % vs 7.84 % pa-
tients (p¼0.1).The present study
Conclusions: Younger patients presenting with AMI were male,
smokers, staying in urban areas, working in corporate sectors,
most of them presented with acute chest pain and were more
likely to have single vessel lesion. There was trend towards better
in-hospital and one year outcome in young patients.Reused radial arterial sheaths in patients
undergoing coronary angiography: Is it really
safe as compared to new sheaths?
Sudeep Kumar, Aditya Kapoor, Archana Sinha
Sanjay Gandhi PGIMS, Lucknow, Uttar Pradesh
Background: Percutaneous intervention through radial route is
fast replacing the traditional femoral route but radial artery
spasm, its occlusion and the pain involved are its major
limitations.
Aims and objectives: There is a lack of published data on safety of
reused radial arterial sheaths which prompted us to evaluate its
safety via a prospective, observational study.
Methods: 1000 patients, undergoing radial angiography were
prospectively randomized to either reused sheath group (n¼493)
or new sheath group (n¼507). The incidence of radial artery
spasm, arterial occlusion and pain scores during various time
points of the procedure were recorded.
Results: There incidence of radial artery spasm were comparable
in reused sheath group when compared to new sheath group (i.e.
21.9% vs. 17.95%, p¼0.12 respectively). Conversely, the incidences
of radial artery occlusion and catheter friction were significantly
more in reused sheath group when compared with the new
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p<0.001 respectively).
Significantly more number of patients in the reused sheath
group felt discomfort as defined by pain score4 (out of a total
pain score of 10), at sheath insertion [73(14.81%) vs. 52(10.26%),
p¼0.03, OR¼1.52, 95%CI¼1.04-2.22], during procedure[77(15.62%)
vs. 46(9.07%); p¼0.002, OR¼1.85(95%CI¼1.26-2.74)] and at sheath
withdrawal[114(23.12%) vs. 77(15.19%), p¼0.002, OR¼1.68(95%
CI¼1.22-2.31)] when compared to the same in the new sheath
group.
The procedural success rate was however comparable: i.e.
505(99.61%) in new versus 490(99.39%) in reused sheath group as
opposed to new sheath group (p¼0.98).
Conclusions: This study demonstrated that reused sheaths
although demonstrate similar rates of radial artery spasm but
increased rates of radial artery occlusion and catheter friction
and although comparable procedural success rates. The pain
involved during the procedure was however seen to be markedly
higher in the reused sheath group. These differences do not
seemingly affect the success of the procedure, therefore keeping
in mind the cost-benefit ratio, the reuse of sheaths in percuta-
neous procedures should not be discouraged, if not
recommended.Endovascular management of traumatic
pseudoaneurysm: Short & long term outcomes
Bishav Mohan, Naved Aslam, Praneet Wander, Varun Mohan,
Rohit Tandon, Shiba Chhabra
Dayanand Medical College & Hospital Unit Hero DMC Heart Institute,
Punjab
Background: Pseudoaneurysms as result of orthopaedic injuries
are quite uncommon. But with increase in operative interventions
and use of implants, its incidence is bound to increase. Selective
angiography is a minimally invasive technique to pin point the
diagnosis and at the same time allows for therapeutic interven-
tion of the same.
Aims and objectives of the study: To review the outcome of
traumatic pseudoaneurysms and to analyze the use of different
endovascular techniques.
Methods: A retrospective review of inpatients from January 2007
to January 2013 requiring transarterial embolization / stenting for
pseuoaneurysm in the limbs. All patients had evidence of pseu-
doaneurysm as proved by radiological findings. Angiographic
intervention in a cath lab was performed, following which pa-
tients were monitored for morbidity and mortality benefits on
short and long term follow up.
Results: Out of the total 14 patients; 8 adults and 1 child under-
went embolisation with polyvinyl alcohol particle / soft metal coil,
where as the remaining 5 adults underwent revascularisation
with covered stent. The mean age of case series was 43.71 19.35
years. The mean follow up period of the group was 13.64 12.28
months. All patients showed significant clinical improvement
with endsovascular management with no procedure related
mortality but one patient required reintervention for residual
pseudoaneurysm.
Conclusion: Endovascular management is the modality of choice
in comparison to other procedures for traumatic pseudoaneur-
ysms in both paediatric and adult patients.Coronary Heart DiseaseBalloon pulmonary valvuloplasty in CHD isolated
valvular pulmonic stenosis
R. B. Vidhyakar, Ajit Anathakrishna Pillai
JIPMER, Puducherry
Background: Balloon pulmonary valvuloplasty has been the first
line of definitive treatment for congenital isolated valvular pul-
monic stenosis. This study aimed to analyse the effectiveness of
Balloon Pulmonary Valvuloplasty (BPV) in congenital isolated
Valvular Pulmonic Stenosis (VPS).
Methods: This retrospective study included patients with
congenital isolated VPS who underwent BPV from December 1988
to July 2013 in our institute. Those diagnosed to have more than
mild VPS with peak instantaneous gradient across PV at least 50
mm Hg on transthoracic echocardiography were considered for
BPV. Right heart catheterization including right ventriculogram
was routinely performed to confirm the diagnosis and to rule out
any significant infundibular stenosis. The size of the balloon
chosen was 120 to 140 % of the diameter of annulus of Pulmonary
Valve (PV) measured in lateral view of angiography. Intervention
was declared as ‘Successful BPV’ when the right ventricle to pul-
monary artery peak to peak gradient was reduced by 50 % or more
at cardiac catheterization and as ‘Partially Successful BPV’ when
the gradient was reduced by less than 50 %. All the patients were
pretreated with beta-blockers.
Results: Out of 143 subjects planned for BPV based on echocardi-
ography, 7 subjects were excluded following right ventriculogram
and the remaining136 patients were included in our study. There
were 63 (46.32 %) males and 73 (53.67 %) females including 51
(37.5%) children less than 12 years of age. The mean age was 18.7
years (range: 1 months to 50years). Balloon could not be negoti-
ated through the stenosed PV in 3 (0.29 %) patients and the pro-
cedure was declared ‘Failed BPV’ in them. Among those who
underwent balloon dilatation, single balloon technique was
employed in 132 (97%) patients and double balloon technique in
the remaining 1 (0.75%) patient. Balloons with step-up diameter
were utilized in36 (27.1 %) patients. The mean of transvalvular
peak to peak gradientmeasured before and after BPVwas 102.45
30.47 and 31.56  17.73 mm Hg (p < 0.0001). The mean of per-
centage reduction in the gradient was 63.81  11.49 %. Interven-
tion resulted in ‘Successful BPV’ in 132 (92.32 %) subjects and
‘Partially Successful BPV’ in 8 (5.67 %) subjects. Out of 5 (3.74 %)
patients with dysplastic PV, ‘Partially Successful BPV’ and ‘Suc-
cessful BPV’ were seen in 1 and 3 patients respectively. The overall
complications noted were vasovagal syncope in 8 (6.04 %) pa-
tients, complete heart block in 1 (0.93 %) patient, cardiac arrest in 1
(0.93 %) patient, left hemiplegia in 1 (0.93 %) patient and femoral
vein thrombosis in 1 (0.93 %) patient. Patients were put on oral
beta-blockers and followed up with annual echocardiographic
assessment. There was further 30% reduction in the peak gradient
and mild to moderate regurgitation of PV could be demonstrated
in 64% % of patients. About 13 to 18 years later, 2 (1.87 %) patients
developed ‘Restenosis’ (echocardiographic peak gradient across
PV at least 50mmHg). Redo procedure resulted in ‘Successful BPV’
in them.
Conclusion: Our study underscores the fact that balloon pulmo-
nary valvuloplasty is definitive curative therapy in congenital
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truly low. On follow up, these patients do extremely well.Intervention
Balloon coarctoplasty in infants presenting with
native coarctation- emergency palliation or
emerging treatment
Jayaranganath M, Kamal Gupta, Usha MK, Anand Subramanian,
Anandkarur
Sri Jayadeva Institute of Cardiovascular Sciences and Research, Banga-
lore, Karnataka
Background: Coarctation of aorta (CoA) in infancy generally pre-
sents with congestive heart failure (CHF) and needs early surgical
repair. Balloon angioplasty (BA) is an alternative to surgical repair
for CoA in children. However, its role in the treatment of native
CoA in neonates and infants remains controversial.
Aims and objectives: Purpose of this study was to report the
midterm outcomes of BA for native CoA in infants.
Methods: Between March 2011 and April 2013, 17 neonates and
infants with native CoA who underwent BA were enrolled. Pa-
tients without recoarctation were designated as group A, while
those with recoarctation or CHF were designated as group B.
Results: There were 13 patients in group A and two in group B. The
mean age was 5.43.7 months (range 0.5-12 months) and the
mean weight was 5.5 2.2 kg (range, 3.010.5 kg). CHF improved
markedly in all patients immediately after BA, with a reduction in
systolic pressure gradient from 41.518.6 mmHg to 7.84 mmHg
(p-value¼0.001). The recoarctation rate was 13.3% (2/15).
Conclusion: The outcomes of BA for native CoA in neonates and
infants were satisfactory with acceptable restenosis rates.
Comparison between prasugrel and clopidogrel
in the patients undergoing percutaneous
coronary intervention e A randomised controlled
study
Nilesh Gautam, Tilak Suvarna, Santosh Dora, Ganesh Jagdale
Asian Heart Institute, Mumbai, Maharashtra
Background: Platelet adhesion, activation, and aggregation play
key roles in both normal haemostasis and pathological throm-
bosis. Clopidogrel plus aspirin dual antiplatelet therapy has
become the standard of care for the support of patients under-
going PCI with stenting largely on the basis of a better tolerability
profile. A growing number of studies have linked poor antiplatelet
response to clopidogrel to adverse clinical outcomes, particularly
coronary ischemia and stent thrombosis
From these limitations, the evaluation of more intensive and
consistent antiplatelet therapy compared with clopidogrel has
been studied. One such agent, prasugrel, a third-generation thie-
nopyridine is the drug we decided to study & review.
Aims and objectives: To compare prasugrel, a new thienopyridine,
with clopidogrel in terms of efficacy and safety profile.
Methods: we randomly assigned 984 patients with scheduled
percutaneous coronary intervention to receive prasugrel (a 60-mg
loading dose and a 10-mg daily maintenance dose) or clopidogrel
(a 300-mg loading dose and a 75-mg daily maintenance dose), for 6
to 9 months. The primary efficacy end point was death fromcardiovascular causes, nonfatal myocardial infarction, or nonfatal
stroke. The key safety end point was major bleeding.
Results: The primary efficacy end point occurred in 8.2% of pa-
tients receiving clopidogrel and 6.7% of patients receiving prasu-
grel (hazard ratio for prasugrel vs. clopidogrel, 0.82; 95%
confidence interval [CI], 0.73 to 0.90; P<0.001). We also found sig-
nificant reductions in the prasugrel group in the rates of
myocardial infarction (6.7% for clopidogrel vs. 5.4% for prasugrel;
P<0.001), urgent target-vessel revascularization (2.5% vs. 1.5%;
P<0.001), & stent thrombosis (1.4% vs. 0.7%; P<0.001). Major
bleeding was observed in 1.8% of patients receiving prasugrel and
in 1.6% of patients receiving clopidogrel (hazard ratio, 1.125; 95%
CI, 0.83 to 1.28; P¼0.07). Also greater in the prasugrel groupwas the
rate of life-threatening bleeding (1.1% vs. 0.9%; P¼0.06), including
nonfatal bleeding (1.1% vs. 0.9%; hazard ratio, 1.25; P¼0.23) and
fatal bleeding (0.2% vs. 0.1%; P¼0.04).
Conclusion: In patients with acute coronary syndromes with
scheduled percutaneous coronary intervention, prasugrel therapy
was associated with significantly reduced rates of ischemic
events, including stent thrombosis, but without significant
increased risk of major bleeding, but increased rate of fatal
bleeding. Overall mortality did not differ significantly between
treatment groups .Our results are comparable to the previous
larger trials like TRITON-TIMI 38, except that that we didn’t
observe increased risk of major bleeding with prasugrel. Larger
studies with large patient population and larger follow up period
are necessary.Usefulness of corsair micro catheter in antegrade
approach for chronic total occlusion angioplasty
Jyotsna
Nizam, Hyderabad, Andhra Pradesh
Background: Corsair microcatheter (Asahi) is a hybrid over the
wire catheter providing support and microcatheter functionality.
Antegrade approach in CTO lesions is limited occasionally by
inability to pass PTCA balloons and stents due to inadequate
channel. Corsair microcatheter passes through microchannels
due to unique design, increasing success rates
Methods: This study was conducted to study the feasibility and
safety of corsair in CTOs using the antegrade approach. Patients
presenting with symptomatic coronary artery disease were
enrolled. Inclusion criteria were 1) angiographic evidence of CTO
(TIMI¼ 0) duration>3 months; 2) a lesion crossed by a guide-
wire.15 patients (22 lesions) who underwent interventions for
CTOs between 2011-2013 were enrolled in the study. Stepwise
guide wires (Fielder FC, XT, Miracle 3,6) were used for antegrade
wiring the CTO lesion. After wiring the target vessel the smallest
balloon (1.1X10 acrostak) or a microcatheter was tried across the
CTO site. Upon failing to cross the lesion corsair was used, sub-
sequently serial balloon dilatations were performed and later
stented with DES. Success was defined by a final TIMI grade 3.
MACCE as death, Q wave MI and emergent CABG. Patients were
followed for 1 year
Results: Procedure success was achieved in 20/22 lesions. There
was no case of coronary perforation, stent thrombosis or urgent
cabg.1 case had contrast nephropathy. On follow up 1 patient
underwent target revascularization.
Conclusions: CTO angioplasty is rewarding with corsair usage,
corsair in CTO is useful ante grade method. Without increasing
chances of coronary perforation.
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angiographic definite stent thrombosis in Indian
sub-continent e A single centre study
Bhupinder Singh, Basvappa Ramesh, Manjunath C. Nanjappa
Sri Jayadeva Institute of Cardiovascular Sciences & Research, Karnataka,
India
Background: The incidence of stent thrombosis (ST) in real-world
practice is not the same as that observed in the various rando-
mised trials. We evaluated the frequency, predictors and out-
comes of ST.
Methods: In this prospective observational cohort study, 2632
consecutive patients who underwent successful percutaneous
coronary intervention (PCI) were followed up for 1 year from the
index procedure.
Results: The cumulative incidence of angiographic definite ST
was 1.4% at 30 days and 1.7% at 1 year. ST elevation
myocardial infarction was the presentation in 82.6% of the
patients of which 21% were in cardiogenic shock. The inde-
pendent predictors for angiographic definite ST were prior PCI,
multivessel disease, emergent PCI, acute coronary syndrome
and complex lesions. The incidence of ST at 1 year was found
to be significantly higher with BMS than DES (OR-2.4, 95%
CI:1.3-4.5). Overall mortality at mean follow-up of 13.9 months
was found to be 36.9%, and 75% of them occurred during the
index hospitalisation. Post procedural thrombolysis in
myocardial infarction (TIMI) flow grade <3, and cardiogenic
shock at the time of presentation were found to be the inde-
pendent predictors of mortality after ST.
Conclusion: In real world scenario, the cumulative incidence of
angiographic definite ST was higher than those observed in
randomised trials. Compared with BMS, DES had significantly
lower incidence of angiographic ST at 1 year, probably contributed
by more use of second generation DES. Prognosis of ST is dismal,
especially in those presenting in cardiogenic shock, or the ones
who did not achieve TIMI 3 flow following PCI.Usefulness of fractional flow reserve guided
percutaneous coronary intervention in decision
making and cost effectiveness: A real world
scenario from developing country
C. N. Manjunath, Gaurav Bhardwaj, L. Sridhar, Prabhavathi,
K. H. Srinivas
Sri Jayadeva Institute of Medical Sciences, Bangalore, KarnatakaObjective: This study was devised in view of the real life applica-
tion of FFR in catheterisation laboratory from a developing world
country and to evaluate the cost effectiveness of the same.
Background: FFR has been proved to be superior to angiograph-
ically driven PCI in various studies also it has been proven to be
economically beneficial. However there is difference between
trials and real life situation. Considering this we conducted this
study and evaluated clinical outcome and cost effectiveness
associated with use of FFR.
Methods: We conducted a retrospective study which included all
patients who underwent FFR in our hospital. Coronary angio-
grams of these patients were retrospectively analysed by two
interventional cardiologists and decision regarding the lesion
were made. The proposed decisions and their associated costs
were compared with the actual procedure and costs incurred with
the use of FFR. Also patients were evaluated for any adverse
outcome after the procedure to the time of analysis.
Results: 38 patients underwent FFR in our hospital. 12 patients
had SVD, 13 patients had DVD, 3 patients had TVD and 2 patients
had LMCA disease. Mean FFR value in our studywas 0.840.09 and
36.8% of all lesions had FFR0.80 and 16.2% had FFR 0.75-0.80. LAD
was the most common vessel interrogated (27 patients). Total 42
lesions were analysed in 38 patients. Concordance between
cardiologist opinion and FFR results were seen in 47.6% lesions.
On basis of angiography alone intervention cardiologists decided
22 lesions to be stented but after estimation of FFR, 16 lesions were
stented. Overall in 22 lesions decision was changed of which 14
lesions were deferred and 8 lesions were those which underwent
PCI. On evaluation total cost of procedures as per decision of
intervention cardiologist was found to be Rs 2603254 and actual
total cost was Rs 2887954 with a difference of Rs 284700, which
was not significant statistically. If further it was considered that
FFR wire was used as guidewire for the patients who later un-
derwent PCI after FFR, and cost of guidewire was reduced from the
actual cost then Rs 207900 was the difference. Out of 38 patients
we were able to contact 32 patients only. Mean duration of follow
up was 12.77.14 mths. Amongst the 32 patients only 2 patients
complained of class II angina. One patient later underwent CABG
and was asymptomatic on follow up.
Conclusion: Despite few number of patients this study reinforces
that clinical trials don’t represent real life scenario and cost
effective analysis may not be achieved in each set of situations.
However, despite the increased cost we support the use of FFR for
guiding revascularisation in intermediate severity lesions as it
helps to classify these lesions correctly into significant or non
significant. More so deferring of insignificant lesions and
attending to significant lesions both are important to improve
outcome.
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coronary artery disease in premenopausal
female population
Gaurav Bhardwaj, L. Sridhar, K. H. Srinivas, P. V. Dattatreya, C. N.
Manjunath
Sri Jayadeva Institute of Cardiovascular Sciences & Research, Karnataka,
India
Objective: This studywas designed to evaluate the risk factors and
angiographic profile of coronary artery disease in premenopausal
females. Traditionally premenopausal females are thought to be
at low risk for coronary artery disease but only few studies have
been done to exactly look for the risk factors and angiographic
picture in this subset of patients.
Background: Coronary artery disease in premenopausal females
appears to have particularly poor prognosis. Evaluation of risk
factors associated and relative importance of risk factors in this
subset of population needs more studies.
Methods: We evaluated 100 premenopausal patients who pre-
sented with acute coronary syndrome or chest pain considered to
be anginal in origin. Traditional risk factors were reviewed in all
patients and association with angiographically detectable coro-
nary artery disease was made. Also, cases were compared with
age and sex matched controls who had normal coronaries.
Results: Out of 100 patients 33 patients presented with Effort
Angina (EA), 15 with Unstable Angina (UA), 4 with NSTEMI and 48
with STEMI. The mean age was 45.676.28 years. Only 2 patients
had no risk factors and 17 patients had all the 4 risk factors
evaluated. Out of all cases 17 patients had normal coronaries, 16
had non-obstructive disease and 65 had significant disease.
Amongst patients with obstructive disease 37 had SVD, 17 had
DVD, 8 had TVD and 5 had significant LMCA disease. Among the
traditional risk factors analyzed no significant difference amongst
the three angiographic groups were seen. On comparative anal-
ysis between cases and controls significant differencewas present
with reference to diabetes, hypertension, total cholesterol, LDL,
TG and BMI. After multivariate analysis DM (p¼0.016), HTN
(p¼0.000) and BMI (p¼0.002) were found to be significantly asso-
ciated with the patient group.
Conclusion: Premenopausal females with coronary artery disease
are not so uncommon entity as initially thought. These patients
have high prevalence of conventional risk factors as compared to
normal population. Majority of these patients had significant
disease in our study. However conventional risk factors failed to
predict the presence of angiographically significant disease in this
group of patients.A randomized comparison of Taxus Element vs
Xience Prime in Indian patients with diabetes
mellitus (TUXEDO INDIA)
Kaul U., Abhaichand R., Patel T., Mullasari A., Prem Chand, Pinto
B., Jain R. et al on behalf of TUXEDO Investigators
Fortis Escorts Heart Institute, New Delhi
Background: The choice of DES in diabetic patients is still a matter
of debate, data from registries and subset analyses of trials
comparing paclitaxel eluting stents vs sirolimus and everolimus
stents have conflicting results. There is no adequately powered
study to answer this question.Methods: TUXEDO India is an ongoing Investigator initiated ran-
domized study comparing Paclitaxel eluting “Taxus Element” with
Everolimus eluting “Xience Prime” in patients with diabetes
mellitus on medical treatment. The inclusion criteria include
multi vessel disease with up to 3 stents in different lesions. Stent
lengths up to 38mms are allowed to be used. Based upon previous
data a sample size of 1830 patients are to be included.
The primary end point of the study is target vessel failure
(Cardiac death, MI and target vessel revascularization) at 1 year.
Stent thrombosis is a secondary end point. The enrollment for the
study should be over shortly with 1610 cases already recruited.
The follow up is ongoing.
Results: Demographic data of 1620 patients in is available. Mean
age 59.0þ9.2 years. Males 77 .6%. Insulin requiring diabetes 33.6%
.ACS was present in (72.8%). Average stent length used was
23.75þ7.19 mms with an average stent diameter of 2.91þ0.35.
Average number of stents used was 1.4þ0.64.
Conclusions: The high risk diabetic patients with 33% requiring
insulin were included in this study with implantation of long
stents in a multi vessel scenario makes it a unique population.
The details of the base line demographic features of this ongoing
study comparing paclitaxel and everolimus-eluting stents will be
presented.Our experience with biovascular scaffold (BVS)
Nilesh Gautam, Tilak Suvarna, Santosh Dora, Swati Kasbekar
Asian Heart Institute, Mumbai, Karnataka
Aim: To study clinical safety & efficacy of BVS.
Background: Bioabsorbable stents have altogether opened a new
perceptive in coronary interventions and a debate on benefits over
bare metallic stents and drug eluting stents. There had been dif-
ference of opinion from experts in this state of art over the tech-
nology, indications of usage, clinical benefits and economics.
Although BVS are bulky & larger than DES (DRUG ELUTING
STENT), BVS are promising alternative to permanent stents &may
eventually be used to solve lingering problem of re-stenosis.
Hence we decided to study BVS.
Methods: Between the months of JAN-JUNE 2013, we got an op-
portunity to deploy 20 BVS. Patients included 15 males (75%) & 5
females (5%) with mean age of 56.4 þ/- 11.1 years. At baseline
diabetes, hypertension, hypercholesterolemia & smoker patients
were present in 8 (40%), 15 (75%), 16 (80%), 9 (45%) respectively. The
patients included those who underwent primary PCI & RESCUE
PCI. Out of 20 patients, 5 were Acutemyocardial infarction cases, 3
were cases of in-stent re-stenosis in whom previously stenting
was done with DES.
Key endpoints of the study include assessment of safety- MACE
(Major adverse cardiac events) & stent thrombosis rates at 30 days;
6; 9, 12, 18 months & 2 years with additional annual clinical follow
up for upto 5 years as well as an assessment of acute performance
of the BVS including successful deployment of stent.
Results: The study demonstrated clinical safety of the BVS as
there was only one ischemia-driven major adverse event (non-Q-
wave MI) at 6 months. Incidence of in stent binary restenosis,
MACE events were zero. In 1 patient with disease in large OM in
whom proximal LEFT CIRCUMFLEX artery (LCX) was stented with
DES previously , BVS could track easily after balloon dilatation of
native LCX reaching the OM. Thus tracking in of BVS through stent
struts into another branch is not an issue. Patients who under-
went BVS implantation in AMI situations were doing well
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clinical spectrum of Ischemic heart disease. Indications for BVS
use will expand further with greater applicability in future. Late
luminal enlargement due to plaque reduction without vessel
remodelling needs confirmation from the outcomes of further
detailed ongoing studies. Further follow up is required for study of
duration of stent bio absorption, restoration of vasomotion,
occurrence of late thrombosis. 1 year results of our ongoing study
are awaited & will be published at a later date.A single centre, multi-operator initial experience
of 4,195 patients at a primary radial intervention
programme in a primary care tertiary level centre
Deepak Padmanabhan, Rajendra K Gokhroo, Satish Kaushik, Sajal
Gupta
JLN Medical College, Adilabad, Andhra Pradesh
Background: There has been an increase the acceptability and the
number of the procedures via the radial approach. We present our
experience pertaining to the clinical characteristics, procedural
details and post procedural outcome of patients undergoing radial
artery access, coronary angiographies over a period of 4 years at a
primary care tertiary level centre.
Materials and methods: A retrospective analysis of all the coro-
nary artery procedures during the last 4 years was done and the
various parameters related to these procedures noted.
Results: In 4,195 procedures performed, success in radial artery
procedures was achieved in 3,975(94.8%) procedures. The average
puncture time and total procedure time was 9.5  3 minutes (min)
and 15  2.5 min in the initial 500 patients, whereas the times
taken in the final 695 patients were just 1.5  0.5 min and 3.0  1.5
min respectively. The total fluoroscopy time was not significantly
different among the groups, when performed by an operator with
training in the femoral route for angiography. Cardiology fellows
needed more fluoroscopy time when mastering the radial route.
Crossover of access sites was seen in 220 patients (5.2%).
Conclusions: Radial access coronary angiographies take less than
4.5 min, with first attempt radial artery access and negligible
complication rates. Prior experience of coronary angiography
helps in the reduction of fluoroscopy time during the learning
curve.The effect of bivalirudin on the outcomes of
primary PCI in STEMI
Manu Bhaskar, K Sivaprasad, Kiran Gopinath, Sunitha, George
Koshy, Prabha Nini Gupta
Medical College, Trivandrum, Kerala
Background: The bleeding outcomes associated with the use of
heparin with Glycoprotein IIb-IIIa inhibitors are known to cause
an increase in mortality. Bivalirudin is being increasingly used as
an alternative anticoagulant with lesser bleed risk and hence
lesser mortality.
Aims and objectives: To study the difference between In hospital
outcomes in patients who are admitted with STEMI and undergo
primary PCI as revascularisation strategy who are administered
unfractionated heparin or bivalirudin as part of the anti-
coagulation regimenMethod: Retrospective data from the hospital records of 198
consecutive patients with ST elevation myocardial infarction who
underwent Primary PCI from October 2012 to June 2013, were
studied. The in hospital outcomes of patients who received Biva-
lirudin alone as the anticoagulant during Primary PCI was
compared with the group of patients who received Unfractionated
Heparinwith provisional use of GpIIbeIIIa inhibitors. The primary
end point was Major Bleeding and Net adverse cardiac events
(composite of Major Bleeding and Major Adverse Cardiac Events,
which is defined as a combination of death, reinfarction, Target
vessel revascularization for ischemia, and stroke) during the
hospital stay
Results: In the setting of Primary PCI, the use of Bivalirudin in
comparison to the use of Unfractionated heparin, with provisional
use of GpIIb- IIIa inhibitors , caused reduced rates of In hospital
Net Adverse cardiac events (6.45 % vs 13.6 %, p¼ 0.10 ) . The all
cause mortality was 3.22% vs 4.04% (p ¼ 0.96). The incidence of
stent thrombosis in the bivalirudin group vs heparin group was
3.2% vs 3.03% (p¼ 0.23). The comparison of TIMIMajor bleed in the
two groups was 0 vs 4. There were 7 cases of TIMI Minor Bleed
(3.53%), 1 case of stroke (0.5%)and 1 case of reinfarction (0.5%) in
the heparin group as compared to no such events in bivalirudin
group.
Conclusions: The incidence of Net adverse cardiac events was
lesser in the Bivalirudin group, chiefly because of the low bleeding
events. The major bleed events in Heaprin arm were associated
with use of GpIIb-IIIa inhibitors, as tirofiban. The net event rates
indicate bivalirudin can be used safely in our population.Comparison of the Framingham 10 year risk
score with a new algorithm (Jai Heart) for the
estimation of coronary heart disease risk: A
nested case-control study of 2068 subjects from
the Indian Atherosclerosis Research Study
Sanjay Kakkar, Jayasree Shankar, Mahesh Chopra
Thrombosis Research Institute, Bangalore, Karnataka
Background: India, the rest of South Asia and the Middle East are
estimated to have amongst the highest prevalence and incidence
rates of coronary heart disease (CHD) in the world. However, there
are few, if any, clinically validated total risk estimation algorithms
developed specifically for South Asian and Middle Eastern pop-
ulations.Furthermore, conventional risk factorsalonedonotappear
toaccount for thehigher incidence, severityandearlieronsetofCHD
observed in this region. Using data from published studies and da-
tabases including Asian, Middle Eastern and African subjects, we
havedevelopedanewCHDrisk estimationalgorithm, JaiHeart, that
incorporates age, gender, ethnicity, 9p21 allelic status, smoking
status, diabetes, family history of premature CHD, anti-
hypertensive treatment, body mass index, systolic blood pressure
and ratio of total cholesterol to high-density lipoprotein level.
Aims and objectives of the study: To compare CHD risk estimation
using the Framingham score against the Jai Heart model in the
Indian population.
Methods: A nested case control study was conducted within the
Indian Atherosclerosis Research Study (IARS), a case-control and
ongoing prospective cohort study of 11,963 subjects investigating
risk factors for CHD in the Indian population led by the Throm-
bosis Research Institute. 1034 cases with confirmed CHD and 1034
age and gender matched controls were selected from the IARS
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variables (age, gender, smoking status, blood pressure and
cholesterol) plus 9p21 allelic status (rs10757278), diabetes history,
family history of premature CHD, anti-hypertensive treatment
and body mass index. The 10 year risk of CHD was calculated for
each participant using both models. The main outcome measure
was the odds of being a case of CHD given a Framingham or Jai
Heart 10 year risk score 20%.
Results: Themean Framingham 10 year score was 6.70 % for cases
and 6.17% for controls (p¼0.034). The mean Jai Heart 10 year risk
score for cases was 23.08% and for controls 15.05% (p<0.001). The
odds ratio for the Framingham score was 1.22 (0.88-1.70, p¼0.24).
Odds ratio for Jai Heart score was 2.82 (2.35-3.40, p<0.001). The
odds ratios for the comparison of quartiles for Framingham scores
were significant only for Q4 vs. Q1: 1.32 (1.03 e 1.69). Odds ratios
for quartile comparisons for Jai Heart scores were significant
across all quartiles: Q2 vs. Q1 1.83 (1.42-2.37), Q3 vs. Q1 2.84 (2.20-
3.66) and Q4 vs. Q1 5.12 (3.93-6.66).
Conclusions: The Jai Heart risk score is potentially superior to the
Framingham risk score at identifying those at a high risk (20%) of
CHD in this study population. The Jai Heart model represents a
viable option for CHD risk estimation in the Asian, Middle Eastern
and African populations for which it has been designed.NT pro BNP (N Terminal pro Brain Natriuretic
Peptide) as a potential marker of disease severity
and adequacy of Percutaneous balloon mitral
volvotomy (PBMV) in rheumatic mitral stenosis
(MS)
Rashi Khare, S. K. Dwivedi, R. K. Saran, V. S. Narain, Sharad
Chandra
King George Medical College, Lucknow, Uttar Pradesh
Background: Rheumatic heart disease is still a common problem
in developing countries. NT pro BNP is widely used as a marker of
CHF. Plasma BNP levels are affected in rheumatic heart disease,
and can be correlated with disease severity and adequacy of PBMV
Aims and objective: To correlate levels of NT pro BNPwith clinical,
echocardiographic and hemodynamic parameters of MS severity
and to correlate levels of NT pro BNP with adequacy of PBMV.
Methods: A total of 36 patients undergoing PBMV and 10 normal
control subjects were enrolled in the study. All enrolled subjects
underwent detailed history and physical examination. All the
tests were done within 12 hours of PBMV and were repeated 12
hours post PBMV and 1 month PBMV.NT pro BNP levels were also
done within 12 hours before PBMV , 12 hours after PBMV and 1
month post PBMV. Treadmill test was done to test the exercise
capacity pre and post PBMV. All enrolled subjects underwent 2
dimensional conventional Doppler, and tissue Doppler imaging.
Transthoracic echocardiography was performed using Vivid 7
echocardiographic unit (General Electric) for tissue Doppler im-
aging. Tissue Doppler Echocardiography derived Strain and Strain
Rate imaging were used for assessment of LA regional longitudi-
nal function using apical 2- and 4-chamber views of the LA before
PBMV and post PBMV at day 1,and at 1 month. Peak Strain and
Strain Rate were measured at each mid-LA segment (septal,
lateral, anterior, and inferior) during ventricular systole (LAs) and
at early (LAe) and late diastole (LAa). LAA contraction velocity was
calculated using trans esophageal echocardiography and corre-
lated with NT pro BNP levels. Invasively cardiac output wascalculated using swan gauz cardiac output catheter. PCWP, pul-
monary artery pressure and other cath data were correlated with
NT pro BNP levels pre and post PBMV.
Results: NT pro BNP levels correlated significantly with the
severity of disease symptoms, the functional capacity, echocar-
diographic findings and hemodynamic data. (p<.05). Strain at
each mid-LA segment (septal, lateral, anterior, and inferior) dur-
ing ventricular systole (LAs), at early (LAe) and late diastole (LAa)
were significantly lower in the patients than in the controls (P <
0.0001). During all 3 periods, most of the segment Strain Rate
values were significantly lower in the patients than in the controls
(P< 0.05). Post PBMV,mean transmitral pressure gradient dropped
significantly from 15.44.7 to 4.61 mmHg (p < 0.05) that corre-
lated significantly with NT pro BNP levels. Strain and Strain Rate
values improved significantly (p < 0.05) in most segments at day 1
and were significantly improved in all segments during all 3 pe-
riods at post PBMV 1 month.
Conclusion: NT pro BNP levels correlate significantly with the
severity of MS and also with adequacy of PBMV.A comparison of clinical outcome of two
pharmaco-invasive strategy post-thrombolysis
in STEMI: PCI within 24 hour versus PCI before
discharge
Vikas Kumar, R. K. Saran, V. S. Narain, Sharad Chandra
King George’s Medical College, Lucknow, Uttar Pradesh
Background: Primary PCI is presently the gold standard for the
treatment for patients with STEMI. But it is still not available in
our set-up round the clock. So, a method of various pharmaco-
invasive strategies has been developed. Facilitated PCI within 3
hours of thrombolysis or various reperfusing agents, historically
has been failed. So, adjunctive PCI, ie PCI within 3-24 hours of
reperfusing agent, and early elective PCI, ie PCI from 24 hours to
before hospital discharge, has becoming the de facto treatment
strategy. Direct comparison of these two strategies is lacking,
that’s why this study is planned.
Aims and objectives: To compare the clinical outcomes of two
pharmaco-invasive strategy post thrombolysis in STEMI, ie PCI
within 24 hour versus PCI after 24 hour but before discharge.
Methods: A total of 40 patients in adjunctive PCI group and 60 pa-
tients in early elective PCI group are included. All the patients un-
derwent detailed history taking to meet inclusion or exclusion
criterias. They are meticulously examined at the time of presenta-
tion. Then patients were thrombolysed if there is no contraindica-
tion. Then they underwent 2-D Trans-thoracic Echocardiography
(Vivid 7 echocardiographic unit General Electric). The patients un-
derwent PCI of infarct related artery. They were followed for 30
days. At the end of 30 days they were again interrogated and
examined for: any cardio-vascular mortality, re-myocardial
infarction, angina leading to hospitalisation, any heart failure hos-
pitalisation, improvement in global cardiac function by 2-D Echo-
cardiography and functional NYHA class.
Result: There is no difference in cardiovascular mortality between
the two study groups (p>0.05). Re-Myocardial infarction and angina
or heart failure leading to hospitalisation was not significantly
different between the two study groups (p>0.05). There was overall
improvement in LVEF as compared to predischarge LVEF, but it was
not significantly different between two groups (p>0.05). There is
improvement in NYHA functional class as compared to
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) S 1eS 3 2 S17predischarge in both groups but again insignificant between two
groups (p>0.05)
Conclusion: In our set-up where primary PCI is not readily avail-
able, pharmaco-invasive strategy is a valuable option, even when
there is much delay in transfer to PCI capable centre after
thrombolysis. Even after 24 hour, PCI can be done with compa-
rable outcome as compared to PCI within 24 hour.Approach to stent thrombosis following primary
PCI: A single-unit experience
Y. Vijayachandra Reddy, M. Ramanathan
Apollo Main Hospitals, Chennai, Tamil Nadu
Background: Acute & subacute Stent thrombosis (ST) occurring
within the index hospitalization is a rare but potentially cata-
strophic complication following PCI for acute STEMI. The man-
agement of such early ST (EST) is challenging, and can be
pharmacological (thrombolysis) ormechanical involving aspiration
thrombectomy (AT) with plain balloon angioplasty (PBA) or repeat
stenting (RS) to plaster the stent thrombus. We present our single-
unit experience in dealing with this problem over the last 10 years.
Material &methods:We retrospectively analysed the cases of EST in
the last 10 years. Our protocol was to review the PPCI result to
ascertain if therewasmechanical failure (MF)ornot. Suspiciousedge
dissection, residual stenosis or suboptimal result were considered
MF; these were taken up for repeat intervention. AT and PBA was
done inall; stentingwasdone for suspicious edgedissectionor if PBA
didn’t yield satisfactory result. EST with very good initial result was
presumed to be due to pharmacological failure (PF) and was treated
with IV thrombolysis with Tenecteplase, followed by angiography
after 24-48 hours. Platelet function assay was not done in any.
Results:Therewere 8 cases of EST (8 out of 300 cases; 2.66%). 6were
male and 2 female (age group 46-78 years). Aspirin, Heparin were
used in all; the second antiplatelet agent was Clopidogrel in 7 and
Ticagrelor in 1. Eptifibatide was used in all of these. BMS was used
in 6 and DES in 2. Single stent was used in 6, 2 had overlapping
stents. Branch vessel occlusion of diagonal or RV branch occurred
in 4 of these. 6 presented between 24 and 48 hours after PPCI; 2
between 48 and 96 hours. 1 had recurrence of ST 48 hours after
repeat stenting. Vessel involved was LAD in 6 and RCA in 2. 5 with
MF underwent AT & PBA but only 2 needed RS. 3 with PF success-
fully reperfused with Tenecteplase and angiography revealed
patent stents without any residual problem. 5 needed inotropic
supports including IABP in 2. LVEF pre-discharge was 32% - 55%.
There was nomortality in-hospital or within 1month. Clopidogrel
was changed to Prasugrel in 1, Ticagrelor in 2 and Ticagrelor was
changed to Prasugrel in 1. Cilostazol was added to all patients.
Conclusions: Early ST following PPCI is rare but responds well to
treatment.Ascertaining if therewasmechanical failureatPPCIhelps
guide treatment approach. Repeat stenting is needed in 25%;
thrombolysis yields good success in presumed PFowing to the “pure
clot”occlusionsituation.CheckingPFAcanprobablyhelpchoosethe
management strategy as well as reduce the incidence of EST.“Reverse Jailing” e A rare phenomenon in
primary PCI (PPCI)
Y. Vijayachandra Reddy, M. Ramanathan
Apollo Main Hospitals, Chennai, Tamil NaduBackground: PPCI for management of acute STEMI is becoming
more popular in our country. PPCI throws up some rare chal-
lenges, not usually encountered in planned PCI in stable settings.
Side branch occlusion during main culprit vessel stenting is a well
recognised entity in this setting. Herewith, we are reporting a rare,
previously unreported phenomenon during PPCI, which we call
“Reverse Jailing”
Aims and objectives: “Side branch jailing” during main vessel PCI
is a known phenomenon and likely when plaque / thrombus
burden is more and ostium of side branch is also diseased, the
severest form being total occlusion of side branch. We report here
the opposite phenomenon of side branch jailing, wherein a total
ostially cut-off side branch opens up very well following main
vessel stenting. We call it “Reverse Jailing” phenomenon. We
present the incidence and features of reverse jailing phenomenon
in our PPCI series.
Methods: We have done a retrospective analysis of the last 100
primary and rescue PCI (failed thrombolysis) done over the last 4
years. Among 100, 62 were male patients and 38 were female
patients. 53 patients had AWMI, 42 had IWMI and 5 had AWMI
and IWMI. 58 had diabetes, 38 had hypertension, 75 had dysli-
pidemia, we analysed all the PCI angiograms specifically looking
for disappearance or appearance of side branches arising from
the culprit lesion area following main vessel PPCI treatment.
Side branches sized more than1 mm only were taken up for
analysis.
Results: In all our PPCIs, we follow MICA (Minimally Invasive
Coronary Angioplasty) technique. In the majority of our PPCI,
Direct stenting was done (90%) and in 10% mini predilatation was
done. The incidence of side branch closure was 6%. “Reverse
Jailing” phenomenon was seen in 4 patients. In 2 patients, the
initially occluded diagonal branch got opened after LAD stenting.
In 1 patient, the PDA branch got opened following RCA to PLB
stenting. In 1 patient, where the stent was placed in LAD to Di-
agonal, previously occluded LAD opened up. The angio films will
be shown during presentation. The likely mechanism is the
disruption of ulcerated plaque/spiral dissection involving origin of
side branch getting sealed by stenting leading to good flow into the
previously occluded branch vessel. No attempt was actively made
for entering the occluded branch vessels.
Conclusion: “Reverse Jailing” phenomenon has not been reported
so far in the literature. The practical importance of this phe-
nomenon is that one need not pursue side branch treatment in
totally occluded side branches until after the main culprit vessel
has been treated, as this step itself could open up the side branch.Long term clinical outcome after percutaneous
coronary intervention in chronic total occlusion
Roopali Khanna, P. K. Goel
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow,
Uttar Pradesh
Background: Chronic total occlusion (CTO) of coronary arteries is
one of the most challenging PCI, usually defined as more than
three-month-old obstruction of a native coronary artery. Percu-
taneous transluminal coronary angioplasty (PTCA) for chronic
totally occluded coronary arteries is associated with a significant
residual stenosis and a high incidence of restenosis.
Aim: The aim of the study was to evaluate the short and long term
outcome of patients of CTO undergoing percutaneous coronary
intervention (PCI) in a single center.
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dergoing PCI between 2006 to July 2013 was done. Data were
retrieved from a computer generated software regarding de-
mographics, coronary anatomy, procedural success, procedural
technique, last available follow up entered into the system on day
to day basis. Procedural techniques, success and short and long
term major adverse cardiovascular events (MACE) including car-
diac death, myocardial infarction and target vessel or non-target
vessel revascularisation (TLR) were assessed.
Results: Mean age was 56.6years(87% were male). Radial
approach was done in 179 (42%), femoral approach in 201 (48%)
and combined femoral and radial approach for contralateral
injection was done in 81 (19%). 30% were diabetic. CTO vessel
distribution e LAD in 164 (39%), LCX in 110 (26%) and RCA in 148
(35%) cases. 238 (51%) were having single vessel disease, 159
(38%) were double vessel and 25 (6%) were triple vessel disease.
Mean number of stents used per patient was 1.63 and mean
length of the stent was 31.3  11.6 mm. Average volume of
contrast used was 295ml (150 ml to 800ml). Retrograde wire
technique was used 25 (0.5%) patients. In 367 (87%) technical
success was achieved. Technical success was defined as the
ability to cross the occluded segment and successfully open the
artery with a < 40% residual stenosis and TIMI 3 flow. There
were 3 deaths (2 due to cardiac tamponade and 1 due to acute
closure due to subintimal passage of wire). Clinical follow up
data of 259 (65%) is present with mean follow up 24.2  12.45
months. In follow up 30 patients were symptomatic. Follow up
angiography was performed in all these cases which revealed in
stent restenosis in 14 (3%). In follow up 2 cases developed stent
thrombosis and total death in follow up were 2.
Conclusion: Elective coronary stenting following successful
recanalization of chronic total occlusion produces good immedi-
ate result and reduces the recurrence of angina, target lesion
revascularization and angiographic restenosis on long-term
follow-up.Effect of primary percutaneous coronary
intervention on arrhythmogenic parameters like
QTc, QT dispersion and T wave peak to end time
changes in patients of acute STEMI
Pawan Kumar Ola, Ranjit Kumar Nath, Neeraj Pandit
PGIMER, Dr RML Hospital, New Delhi-01
Background: Acute STEMI is associated with significant
arrhythmia or cardiac arrest. QT prolongation can occur in the
setting of ischemia or acute STEMI as a risk factor for arrhythmia.
The importance of dispersion of repolarization in the genesis of
ventricular arrhythmias has been shown in both experimental
and clinical electrophysiologic studies.
Aims and objectives: The goal of this study was to evaluate the
effect of primary percutaneous coronary intervention (PCI) in
acute STEMI patients on arrhythmogenic parameters like cor-
rected QT interval (QTc), QT dispersion (QTd) and T wave peak to
end (TPE) times.
Methods: In this study we enrolled a total of 186 patients (130
males, 56 females) of acute STEMI who were eligible for primary
PCI. All patients underwent successful PCI with TIMI flow grade
3 post PCI with a door to balloon time of < 90 minutes. The QT
data were manually measured with a ruler at admission and 24
hours after primary PCI. To exclude the effect of heart rate onQT interval, the QT interval was corrected according to the
Bazett formula. The end of T wave was considered the point of
return to the iso- electric line. ECGs in which QT interval was
not measurable in more than 8 leads were excluded from
the study. Other exclusion criteria were history of prior MI,
atrial fibrillation, QRS > 120 ms or any drugs affecting QT
intervals.
Results: After primary PCI we found that there was a significant
reduction in QTc (mean 47035 vs 43030; p < 0.001), QTd (mean
954.0 before PCI vs 653.5 after PCI; p < 0.001) and TPE (mean 95
2.5 ms before PCI vs 702.5 ms after PCI; p < 0.001).
Conclusion: Our findings suggest that ischemia induced QTc, QTd
and TPE are important arrhythmogenic parameters responding to
successful primary PCI. These parameters may be used as simple
and non-invasive markers for successful reperfusion and clinical
outcomes.The predictors of outcome of out of hospital
cardiac arrest in territory care center
B. C. Srinivas MD, DM, Vivek Singla MD, C. M. Nagesh MD, DM,
Babu Reddy MD, DNB, C. N. Manjunath MD, DM
Sri Jayadeva Institute of Cardiovascular Sciences and Research,
Bengaluru, Karnataka, India
Background: OHCA (out of hospital cardiac arrest) is a leading
cause of death in first world countries. OHCA patients depends
upon number of variables. However, in India, there is not much
data available on outcome of OHCA. There is need to analyze that
data so that adequate intervention can be done to further improve
outcome.
Aims and objectives of the study: To study the outcome in sur-
vivors of out of hospital cardiac arrest (OHCA) in territory care
centre of North India and to analyze role of various clinical and
biochemical parameters in predicting outcome.
Methods: This prospective study was done in emergency of Day-
anand Medical College & Hospital, Ludhiana over one year. Pa-
tients who were admitted after OHCA and revived following CPR
were enrolled for the study. The clinical, biochemical and de-
mographic parameters of the patients were noted and correlated
with the outcome.
Results: A total of 49 patients were admitted after out of hos-
pital cardiac arrest to the emergency. 18 (36.73%) patients sur-
vived to hospital discharge and 31 (63.26%) patients expired or
took discharge in a critical condition and ultimately expired.
The mean age of patients was 58.06  15.13 years and males
constituted 67.35%. Diabetes was the most common comorbid-
ity. Mean time to arrest to hospital was 7.44  6.86 minutes
(survivors) compared to 13.23  8.06 minutes (non survivors)
(p value ¼ 0.009). Mean duration of stay was more among dis-
charged (p value ¼ 0.006). Patients presenting with VT/VF
(p value ¼ 0.003) as first monitored rhythm compared to asystole
(p value ¼ 0.004) had better outcome. The data showed that VT/
VF, duration of hospital stay, raised urea and creatinine, time to
arrest to first help and hospital were predictors of good
outcome. There was no role of bystander CPR in predicting
outcome in our study.
Conclusion: The present study concludes that the shorter interval
from arrest to reaching the hospital and shockable rhythm were
associated with better outcome in patients of OHCA (out of hos-
pital cardiac arrest).
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function in patients of rheumatic mitral stenosis
and immediate effect of percutaneous
transvenous mitral commissurotomy on it
B. C. Srinivas MD, DM, Vivek Singla MD, C. M. Nagesh MD, DM,
Babu Reddy MD, DNB, C. N. Manjunath MD, DM
Sri Jayadeva Institute of Cardiovascular Sciences and Research,
Bengaluru, Karnataka, India
Background: Mitral stenosis (MS) affects right ventricular (RV)
function as a result of myo-cardial and hemodynamic factors. RV
function is the major determinant of clinical outcomes.
Aims and objectives: The aim of this study was to evaluate RV
function in rheumatic MS patients and to evaluate the immediate
effect of percutaneous transvenous mitral commi-ssurotomy
(PTMC) on it. And whether it can be a criteria for early interven-
tion in patients of rheumatic MS in whom there is difficulty in
assessing pulmonary hypertension.
Methods: In this study we enrolled a total of 86 consecutive pa-
tients (58 females, 28 males) with isolated rheumatic MS, all in
sinus rhythm, undergoing PTMC between August 2011 to July
2013. Patient’s mean age was 247 years. All patients underwent
successful PTMC by anterograde trans-septal approach using an
Inoue balloon. Right ventricular systolic pressure (RVSP) and
tricuspid annular plane systolic excursion (TAPSE), a parameter of
RV longitudinal function were assessed by conventional echo-
cardiography, while peak systolic (Sm), peak early diastolic (Em)
and peak late diastolic (Am) annular velo-cities of tricuspid valve
annulus were assessed by tissue Doppler imaging echocardiog-
raphy. All these parameters were assessed before and on the next
day after PTMC.
Results: Next day after successful PTMC, TAPSE increased from
16.112.1 mm to 19.132.59 mm (p< 0.05), Sm increased from
10.301.6 cm/s to 13.261.37 cm/s (p< 0.05) and Em/Am ratio
increased from 1.150.12 to 1.570.17 (p< 0.05). There was a sig-
nificant decrease in RVSP from 56.418.6 to 27.211.4 (p <0.05)
post PTMC.
Conclusion: TAPSE and tricuspid annulus tissue Doppler indices
were able to assess RV dysfunction in rheumatic MS patients and
they were significantly improved in the immediate post PTMC
period. So,the assessment of RV dysfunction can be a simple, non-
invasive criteria for intervention in patients of rheumatic MS
specially in those patients in whom there is difficulty in assessing
pulmonary hypertension. Though further work using larger
number of patients is needed to confirm our findings.“Hemoptysis as sentinel bleed” e A “Diagnostic
red flag” of aortic pseudoaneurysm
Y. Vijayachandra Reddy, M. Ramanathan
Apollo Main Hospitals, Chennai, Tamil Nadu
Background: Hemoptysis is a common symptom in several lung
diseases. An extremely rare cause of hemoptysis is a leaking aortic
aneurysm (AA) or pseudoaneurysm (APsA) with aortobronchial
fistula. This possibility is almost never considered in the doctor’s
office or in emergency room (ER) due to its rarity. However, in
certain situations such as previous aortic surgeries for PDA or
Coarctation, or in previous road traffic accidents (RTA), Aortic PsA
is common and should be thought of as an important first diag-
nosis. Hemoptysis due to aortobronchial fistula can initially bevery mild owing to the serpiginous fistulous tract in inflamed
tissues. This could be a “sentinel bleed” heralding a massive
exsanguinating bleed later and should be acted swiftly upon.
We report a rare case where a patient presented to us with an
episode of hemoptysis as a sentinel bleed, due to leaking post-
traumatic Psuedoaneurysm of Aortic isthmus. He also had mul-
tiple challenging problems and was successfully treated with
hybrid thoracic endovascular aneurysm repair (TEVAR).
Case report: A 52 year old diabetic, hypertensive gentleman pre-
sented to ER with history of mild hemoptysis for 2 days with fever
and mild backache. He was treated for chest infection and a
routine cardiac evaluation was sought. There was past history of
road traffic accident before 19 years withmultiple left rib fractures
and leg fractures needing orthopaedic surgery. He had chronic
osteomyelitis following that and was on intermittent antibiotics
for 3 years.
Initial clinical evaluation in ER was unremarkable but for
tenderness over lumbar spine. Chest X ray showed mediastinal
widening with calcification of aortic isthmus area. CT thorax and
abdomen revealed calcified thoracic aortic PsA abutting the left
subclavian artery (LSCA). There were multiple challenges in the
treatment:
Blood culture revealed MRSA. Open repair was considered very
risky and TEVAR was chosen with antibiotic cover for 1 year.
LSCA had to be covered by the stent graft as the proximal
landing zone was insufficient, needing common carotid subcla-
vian grafting prior to TEVAR
Left vertebral artery (LVA) had separate origin just before the
LSCA and its jailing had to be avoided
Both femoral and external iliac arteries were only 5 mm sized
needing extraperitoneal conduit placement to aid TEVAR
procedure
A team of endovascular specialist, vascular surgeon, cardio-
thoracic surgeon, orthopaedic surgeon and infectious diseases
specialist was involved in the management. Hybrid procedure
with operative debranching of LSCA with carotid bypass and right
common iliac conduit was done followed immediately by TEVAR
in cath lab using 30/30/150mm self-expandanble Valiant proximal
free flow stent graft (Medtronic, USA) covering the LSCA and
sparing the LVA. Check aortography at 6 months revealed no
endoleak.
Learning points: Hemoptysis in those with a remote history of
RTA could be due to a ruptured aortic isthmus pseudoaneurysm
with aortobronchial fistula. Evenmild hemoptysis in this setting is
very important as this could be a warning “sentinel bleed” for a
catastrophic exsanguinating bleed later.Assessment of early radial artery injury by high-
resolution ultrasound after transradial coronary
intervention
Rajkumar Nune, Rama Kumari N., Sai Satish O., Abishek T.,
Seshagiri Rao D.
NIMS, Hyderabad, Andhra Pradesh
Background: Although transradial coronary intervention (TRI)
has been developed to minimize the bleeding and to improve the
quality of life, radial artery injury is a problem. The present study
was undertaken to compare the early radial artery injury after
TRI between first-TRI and repeat-TRI by high resolution
ultrasound.
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coronary angiogram through transradial route were included. We
compared the radial artery findings between first-TRI patients
(n¼63) and repeat TRI patients (n¼20). The Radial Artery (RA) was
examined by ultrasound before and one day after the procedure.
Results: Compared with first-TRI group, the mean Radial Artery
(RA) diameter of repeat-TRI one day after the procedure
decreased significantly (p 0.005). In first-TRI group, the mean RA
diameter was (2.20.35) and (1.70.37) mm before procedure
and one day after the procedure respectively (p 0.005). In
repeat-TRI group, the mean RA diameter was (2.10.6) and
(1.60.36) mm before procedure and one day after the proce-
dure, respectively (p 0.005). The early radial injuries and intimal
thickening were compared between first-TRI and repeat- TRI.
The mean intima-media thickness of RA was (0.40.22) mm and
(0.590.13) mm before procedure and one day after the proce-
dure in first-TRI group. The mean intima-media thickness of RA
was (0.480.29) mm and (0.680.27) mm before procedure and
one day after the procedure in repeat-TRI group. Compared
with first-TRI group, the mean intimal thickening was increased
significantly in repeat-TRI group one day after the procedure (p
0.06). Linear regression analysis revealed that diameter,
repeated TRI procedure were the independent predictors of the
intimal thickening.
Conclusion: The lumen diameters were smaller in repeat-TRI
patients than in first-TRI patients due to intima-medial thick-
ening, in the radial artery. Care should be taken when the radial
artery is used as a conduit in coronary artery bypass graft surgery,
particularly in patients who have undergone TRI.
Keywords: Transradial Coronary Intervention (TRI), Radial Artery,
High-resolution ultrasound.Study of clinical profile and atherosclerotic risk
factor assessment in slow coronary flow with
normal coronary angiogram
Awadhesh Kumar Sharma, Neeraj Pandit, Ranjit Kumar Nath,
Ajaykumar Sharma, Ajay Raj, Puneet Sondhi
PGIMER, Dr RML Hospital, New Delhi
Background: Angina pectoris is usually caused by atherosclerotic
narrowing of the epicardial coronary arteries. In up to 20 percent
of patients with anginal chest pain, the coronary angiogram does
not reveal a significant narrowing of the epicardial coronary ar-
teries. Slow Coronary Flow (SCF) is a phenomenon in which there
is a delayed opacification of epicardial arteries in the absence of
occlusive disease. Although the pathogenesis of this syndrome is
controversial, several studies have suggested that it is mainly
caused by endothelial microvascular dysfunction. There is also
a correlation between SCF and abnormal atherosclerotic
parameters.
Aims & objectives: This study was designed to evaluate the clin-
ical profile & atherosclerotic risk factor assessment with slow
coronary blood flow, in patients who have normal coronary
angiogram
Methods: This is a prospective, single center registry which en-
rolls all patients with slow coronary flow and normal epicardial
coronary angiograms recruited from cardiology wards and out-
door cardiology clinics of PGIMER & Dr RML Hospital, New Delhi
due to unstable angina or non specific chest pain, between April
2012- April 2013.A total 110 patients were enrolled in the study in
the above mentioned period. And 50 controls age matchedsubjects with no evidence of Ischaemic heart disease from general
medicine OPD on the basis of history and basic investigations Out
of 110 patients 66(60%) were male and 44(40%) were female with
mean age group of 5812 years.
Each patients’ s angiogram was evaluated for TIMI flow grade,
corrected TIMI frame count (CTFC) and Clearance scores. Since
the Left Anterior Descending (LAD) artery is the most important
artery and its blood flow is highly correlated to other coronary
arteries flow, we continued the statistical analysis in reference to
the CTFC of the LAD. The Corrected TIMI Frame Count ( CTFC) and
the Clearance rate score were highly correlated. There was also a
high degree of correlation between the different blood vessels.
Apo B and Apo A-1 will be determined by immune electrophoresis,
and Lp (a) will be determined by immune radiometric assay.
Results: Retrospective analysis of risk factors assessment in these
patients revealed that out of 110 patients 22patients ie 20% had
family history of coronary artery disease, 66 patients ie 60% were
chronic smoker, dyslipidemia was found in 33 ie 30% of the total
cases. History of diabetes mellitus type 2 was present in 45 ie 41%
and hypertension was present in 50 ie 45% of the cases. Abnor-
mality in newer atherosclerotic markers like increased values of
Lpa, hs CRP, Apo B/Apo A were found in 65 ie 59% of cases.
Conclusion: In patients with normal coronary arteries, slow
flow is highly correlated to the presence of known atherosclerotic
risk factors with highest correlation to current Smoking status.EchocardiographyPrevalence of CAD in valvular and non valvular
cardiac pathologies undergoing surgery
Ashish Agarwal
Sri Jayadeva Institute of Medical Sciences, Bangalore, Karnataka
Background: The prevalence of coronary artery disease (CAD) in
patients undergoing surgery for valvular heart disease (VHD)
varies widely among studies. The objective of the present study
was to determine the prevalence of CAD in patients undergoing
surgery for various valvular as well as non-valvular cardiac
pathologies.
Methods: From October 2011 to January 2013, 300 patients, with
various valvular and non-valvular pathologies were identified and
selected for the study. All patients with age  40 years and an
indication for open heart surgery underwent pre-operative coro-
nary angiogram and were included in the study. Significant CAD
was defined as coronary stenosis  50%
Results: The mean age was 51.5  9.02 years. 178 (59.3%) patients
were males and 122 (40.7%) patients were females. Out of 300
patients, 270 (90%) patients had VHD and 30 (10%) patients had
non-valvular heart disease (NVHD). Rheumatic heart disease
(RHD), mitral valve prolapse (MVP), degenerative aortic valve
disease (DAVD) and bicuspid aortic valve (BAV) was present in 161
(53.7%), 17 (5.7%), 60 (20%) and 32 (10.7%) patients respectively.
Patients with DAVD were significantly older (mean age 61.77.04
years, p<0.001) andmoremales (42 patients, 70%, p<0.05). Overall,
26 (8.7%) patients were found to have significant CAD. CAD was
significantly more common in VHD patients (25 patients, 9.3%) as
compared to non-valvular etiologies (1 patient, 3.3%, p<0.05). In
the valvular group, DAVD patients had maximum incidence of
CAD (14 patients, 23.4%, p<0.05). There was no significant differ-
ence in the prevalence of CAD in patients with RHD (4.9%), MVP
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) S 1eS 3 2 S21(5.9%), BAV (6.2%) and non-valvular etiologies (3.3%). In the group
with CAD, the presence of variables such as age >60 years, male
sex, typical angina, HT, dyslipidemia and smoking was signifi-
cantly greater as compared to those with normal coronaries.
Conclusion: The overall prevalence of CAD in the present study is
8.7%. The prevalence of CAD among rheumatic VHD patients is
low, whereas it is high among those DAVD.Role of myocardial contrast echocardiogram in
detection of coronary artery disease in new onset
acute heart failure
Praveen Sreekumar, C. N. Manjunath, K. S. Ravindranath,
Dhanalaskshmi
Sri Jayadeva Institute of Cardiovascular Sciences and Research,
Bangalore, Karnataka
Background: Myocardial contrast echocardiography (MCE) is a
recent non invasive imaging tool for evaluation of coronary
perfusion of the myocardium and is less well studied in heart
failure patients to differentiate ischemic and non ischemic car-
diomyopathy. Differentiation has prognostic implications in the
management and can avoid unnecessary angiograms in these
patients. Safety of myocardial contrast agent is well established.
Objectives: To assess the sensitivity, specificity, positive and
negative predictive value of myocardial contrast echocardiogram
in detecting myocardial perfusion defects in patients presenting
with heart failure assessed with coronary angiogram as the gold
standard.
Methods: 27 patients presenting with new onset decompensated
heart failure were included in the study. Patients with prior
myocardial infarction, those below 18 years, who were moribund
enough that coronary angiogram could not be performed and
patients with bleeding diathesis were excluded. After an intrave-
nous injection of DEFINITY (perflutren lipid microspheres which
are composed of octafluoropropane encapsulated in an outer lipid
shell of (R)ehexadecanoic acid), themicro spheres were destroyed
with high energy ultrasound of myocardial index of 1.4 given for a
short period ("flashing"). The rate of micro bubble appearance
within the LV wall was observed, to assess the myocardial
perfusion. If perfusion defect was present, the pattern of perfu-
sion defect was compared with coronary angiogram, for correla-
tion of perfusion defects with significant stenosis of the epicardial
coronary artery sub serving that area of. myocardium
Results: 27 patients were included in the study, The mean age of
patients was 53.89  16.4 years. There were 17 males (63%) and 10
females (37%). Themean NYHA class of breathlessness was 2.40
2.2 and mean ejection fraction was 35  15.02 %. There was sig-
nificant agreement between the presence of myocardial perfusion
defect onMCE and presence of obstructive coronary artery disease
on angiogram (kappa value of k ¼ 0.705). The sensitivity, speci-
ficity, positive predictive value and negative predictive value of
myocardial perfusion defect on MCE was 78.57%, 92.30%, 91.67%,
80% respectively. The power of study was 78.57%. The highest
correlation of perfusion defect and poor coronary artery flow
(< TIMI II flow) was seen in LAD territory (k ¼ 0.779), followed by
LCX territory (k ¼ 0.757), and RCA territory (k ¼ 0.514).
Conclusions: Myocardial contrast echocardiogram is a safe, non
invasive and cost effective method of evaluation of possible cor-
onary disease in patients with acutely decompensated heart
failure. MCE is highly specific to rule out coronary artery disease
with a specificity of 92.3%. The perfusion defect correlated withangiographic poor flow (<TIMI II flow), withmaximum correlation
in LAD territory, followed by LCX territory and least in RCA
territory.Surrogate echocardiographic parameters for
successful balloon mitral valvuloplasty
Sreekanth, Ajith Anathakrishna Pillai, Raja Selvaraj, Hari Chandra
Kumar K. T., Geofy George
JIPMER, Puducherry
Background: Even though many echocardiographic parameters
have been proposed for assessing the severity of mitral stenosis
and right ventricular dysfunction, scant data is available where in
these parameters are tested as surrogates in the context of
Balloon Mitral Valvuloplasty (BMV). The predictive value of many
of these parameters in predicting success of BMV as against
improvement in Mitral Valve Area (MVA) can be very useful.
Objectives: To find out the utility of surrogate echocardiographic
parameters like mitral valve separation index (MVSI), left atrial
volume (LAV), right ventricular systolic pressure (RVSP), tricuspid
annular systolic excursion (TAPSE), tricuspid annular systolic
velocity (S wave) and right ventricular Tei Index (TEI) in predicting
success of BMV and their relation to MVA.
Methods: Prospective single center study involving 49 patients
undergoing elective BMV. Echocardiographic measurements were
taken before and 24 hours after BMV and statistical analysis was
carried out.
Results: Mean age of the study population was 31 years
(SD9.55). BMV was successful in 38/49 patients. MVA increased
from mean of 0.89 (SD 0.16) to 1.53 ( SD 0.22) cm2 (p<0.01),
MVSI increased from 0.62 to 0.91mm (p<0.01), LA volume
decreased from 64.5 to 56.2mm3 (p<0.01), RVSP decreased from
57.9 to 43.5mm of Hg (p< 0.01), TAPSE increased from 22.2 to 26.3
mm (p<0.01), and S wave from 11.3 to 13.6 cm/sec (p < 0.01), and
TEI decreased from 0.27 to 0.23 (p<. 01). RVSP and MVSP showed
strong correlation with improved MVA. Area under Receiver
Operating Characteristic (ROC) curve analysis showed percent-
age RVSP reduction to be best predictive of MVA followed by
change in MVSI.
Conclusions: All surrogate markers showed favorable improve-
ment following BMV with RVSP reduction and MVSI showing
maximum predictability for change in MVA. The other right ven-
tricular function indices and LA Volume poorly predicted MVA
improvement.Association between epicardial adipose tissue
and waist hip ratio in patients with multi vessel
coronary artery disease in Indian scenario
Balamurugan R., Bathri Narayanan, Venkatesan S., Rajasekhar
Ramesh, Dhandapani, Ravi M. S., Meenakshi K., Muthukumar D.,
Swaminathan, Ravi Shankar, Suresh Kumar
Madras Medical College, Chennai, Tamil Nadu
Introduction: In the era whenmetabolic syndrome and obesity are
growing in population, interest in visceral fat accumulation like
Epicardial Adipose Tissue (EAT) as a marker of Cardiovascular risk
seems more appropriate. EAT is a visceral fat depot of the heart
located along the large coronary arteries on the surface of the
ventricle and apex. In TTE, EAT was defined as an echo free space
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) S 1eS 3 2S22between the outer wall of the myocardium and the visceral layer
of pericardium. EAT was an independent risk factor for CAD like
other traditional risk factors.
Aim: To identify the association between waist hip ratio and
Epicardial adipose tissue in patients with multivessel coronary
artery disease.
Methodology: 50 consecutive patients with multi vessel CAD
detected by Coronary angiography were the subjects of the study.
The study was done in the department of Cardiology in tertiary
care hospital setting from April 2013 to July 2013. Patients with
Acute Coronary syndrome and age<40yrs were excluded from the
study. 25 normal persons were included as controls .In all these
patients Waist Hip Ratio was measured. Waist circumference was
measuredmidway between lowest palpable rib inmid axillary line
and iliac crest (at the level of umbilicus). Hip Circumference was
measured at the maximumwidth of buttocks. EAT was measured
using Trans Thoracic Echocardiography in Parasternal Long Axis
view anterior to the right ventricle in end diastole. The relation
between EAT, Waist Hip Ratio with multivessel CAD were evalu-
ated as well. Serum lipid levels was also analysed for any corre-
lation with EAT.
Results: The mean EAT thickness in the study group was 7mm
(Range 5 to 9mm). Control Groupwas 3mm(Range 2 to 4mm). There
was no linear correlation between WHR and EAT.
Conclusion: EAT thickness has an independent predictive value for
severity of Coronary artery disease. There is no linear correlation
betweenwaist hip ratio and epicardial pad of fat. Echocardiography
is a simple non invasive tool for clinicians in assessing the EAT.RVOT pacing versus RV apical pacing:
Echocardiographic assessment of LV function
Vijaya Bharat, B. Prakash, A. Jaiswal
Tata Main Hospital, Jamshedpur, Jharkhand
Background: Long term pacing from RV apex is expected to
adversely affect the LV function. Alternate site pacing, especially
from the posterior wall of RVOT has been proposed as the closest
mimic to physiological depolarization. Therefore myocardial
disarray associated with apical pacing may not occur with RVOT
pacing. However, there are not enough clinical reports to sub-
stantiate such benefits.
Aim: To objectively assess for any advantage in LV function with
RVOT pacing over RV apical pacing.
Material and methods: From September 2007 to May 2012, sixty
four patients underwent RVOT pacing in our institution. For this
study we selected patients who fulfilled the inclusion criteria:
completed more than one year of single chamber pacing with the
lead tip in RVOT, 80-100% pacing frequency as observed in the
follow up clinic, absence of myocardial infarction/ coronary
revascularization, significant valve or myocardial disease,
freedom from significant co morbid renal, pulmonary or hepaticTable 1
Parameter RVOT Pacing Mean (SD)
QRS duration in ECG 132 ms (20.73)
Left Atrial size 3.58 cm (0.44)
LV ID in diastole 4.37 cm (0.63)
LV ID in systole 3.02 cm (0.65)
Ejection Fraction 60.1 % (10.2)
Fractional Shortening 32.0 % (7.73)diseases. Twenty patients, sixteen males and four females in the
age group of 48 to 67 years fulfilled the above criteria. Pacemakers
were implanted for symptomatic sick sinus syndrome or idio-
pathic complete AV block. We selected an age and sex matched
control of twenty patients with RV apical pacing who fulfilled the
inclusion criteria. Apart from routine clinical history and exami-
nation, QRS duration in surface ECG was measured and trans-
thoracic echocardiography was done. Measurements of left
atrium and LV internal dimensions and fractional shortening
were taken in the long axis parasternal view. The average values
of LV ejection fraction as calculated in the M mode and by Simp-
son’s method were noted.
Result: QRS duration with RVOT pacing was significantly lower
than RVA pacing. LV dilatation was also less with RVOT pacing as
shown by lower values of LV internal dimensions. The other pa-
rameters did not differ significantly.
Conclusion: In this small study of twenty patients with follow up
period of one to five years, there was less LV dilatation with RVOT
pacing. Observations in a larger group with longer follow up and
pre pacing echocardiography data will substantiate the superior-
ity of RVOT pacing.Relationship between swirling pattern of
spontaneous echo contrast and LA thrombus in
patient with mitral stenosis
P. Suresh Kumar, Bathri Narayanan R., Kalyanaraman,
Dhandapani V. E.
Madras Medical College, Chennai, Tamil Nadu
Background: Spontaneous echo contrast (SEC) is the presence of
dynamic, smoke-like echoes seen while performing Trans
Esophageal Echo (TEE), frequently in patients withmitral stenosis.
Left atrial (LA) spontaneous echo contrast was diagnosed by the
presence of dynamic smoke like echoes in the LA cavity and LA
appendage (LAA) with swirling motion distinct from white noise
artefact after adjusting the gain setting properly. Swirling pattern
may be either clockwise or anticlockwise in nature.
Aim and objectives: The aim of the study is to determine the
relationship between Swirling pattern of Spontaneous Echo
Contrast in severe Mitral Stenosis and LA/LAA clot formation.
Methodology: This observational study was conducted using TEE
in the department of cardiology in a tertiary care setting from
October 2012 to July 2013. Every patient with severemitral stenosis
presenting for PTMC was evaluated before procedure for swirling
pattern in spontaneous echo-contrast, rhythm and LA/LAA
thrombus on TEE. Data were analyzed to determine the relation-
ship between Swirling pattern of SEC in Mitral Stenosis and LA/
LAA clot formation.
Results: A total of 60 patients with severe mitral stenosis were
studied. Out of which, 46pts (77%) of patient had Spontaneous
echo contrast. The patients with Spontaneous Echo contrast wereRV Apical Pacing Mean (SD) P value * significant < 0.05
160 ms (22.11) 0.000319*
3.815 ms (0.50) 0.128765
4.80 cm (0.62) 0.035356*
3.43 cm (0.57) 0.037882*
55.0% (9.13) 0.109196
28.8 % (6.03) 0.15577
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which 36 (78%) patients were females and 10(22%)weremales. Out
of 46patients, 38 patients (83%) had anticlockwise swirling pattern
of SEC and remaining 8 patients (17%) had clockwise swirling
pattern.. Out of 46 patients, LA/LAA clot were seen in 14 patients
(30%), all them had anticlockwise pattern. LA/LAA clot was not
seen in patients having clockwise swirling pattern. 38 patients
(83%) were in sinus rhythm and 8 patients (17%) were in Atrial
Fibrillation. In patients with Atrial Fibrillation, only Anticlockwise
Swirling pattern of SEC were noted and all had LA/LAA clot. Mean
LAA emptying velocity in all these patients was 0.20m/s (range 0.1
- 0.48) and is more severe in anticlockwise swirling pattern.
Conclusion: Left atrial hemodynamics and its relationship with
auto contrast is not fully studied. Our observation is that LA/LAA
clot formation is less likely if there is clockwise movement. Exact
mechanism of such phenomenon is to be explored further.Prevalence of right atrial thrombosis in atrial
fibrillation
Jagadeesh J., Hemanath T. R., Sundar C., Venketesan S.,
Dhandapani
Madras Medical College, Chennai, Tamil Nadu
Introduction: This study was undertaken to look into the preva-
lence of right atrial (RA) chamber thrombosis in patients having
atrial fibrillation (AF)
Methods: 72 patients having atrial fibrillation for various etiology
were included in the study. Those patients who were already on
anticoagulant were excluded from the study. Transthoracic and
Trans-esophageal echocardiography were done to assess Right
atrial thrombi and spontaneous echo contrast. Chambers such as
right, left atrium and ventricles and appendages were measured.
30 patients with sinus rhythm were taken as controls.
Results: Patients with atrial fibrillation had larger right atrial di-
mensions (mean RA minor axis in AF patients was 5.2 cm
compared to mean RA minor axis 3.8cm in controls) and lower
TAPSE (Tricuspid annulus planar systolic excursion ) (mean TAPSE
in AF group was 13mm compared to mean TAPSE of 19mm in
controls) compared with those patients in sinus rhythm(p<0.01).
10 patients had thrombus in right atrium and 23 had thrombus in
left atrium. Spontaneous echo contrast was noted in 26 patients in
right atrium and 42 patients in left atrium. No patients with sinus
rhythm had evidence of thrombus in either atria. Patients with
right atrial thrombus had larger right atrial dimensions (p < 0.01).
Spontaneous echo contrast was detected in all patients with
thrombi.
Conclusion: In patients with atrial fibrillation right atrial cham-
bers are also equally important in terms of thrombus formation.
Although no incidence of pulmonary embolism were noted in our
study it is prudent to assess right atrium in atrial fibrillation pa-
tients for its prevention.Right ventricular systolic function assessment by
tissue-Doppler echocardiography in acute
pulmonary thromboembolism
Kosuri Nagamurali, M.S Aditya, Abhisheka Kumar, Sai Satish,
Seshagiri Rao
Nizam’s Institute of Medical Sciences, Hyderabad, Andhra PradeshBackground: Assessment of the right ventricular (RV) function by
echocardiography in patients with pulmonary thromboembolism
(PTE) is complex and frequently qualitative. Tissue Doppler has
been used for the semiquantitative assessment of this chamber,
although with some limitations.
Aim and objectives: To evaluate RV function in acute PTE using
various echocardiographic parameters
Material and methods: Patients admitted with PTE during July
2012 to June 2013 in our institute were studied using conventional
and tissue-Doppler echocardiography within 24 hours after diag-
nosis. Fractional area change (FAC), RV free wall thickness, TAPSE,
myocardial velocities (s’) at annulus and RV myocardial perfor-
mance index (MPI) were obtained and RV dysfunction was
diagnosed.
Results: During abovementioned period 30 patients [18 (60%) men
and 12 (40%)women] were admitted in our institute. Average age
of the study population was 55  17 years. PTE was found to be
massive in 8 (26.67%), submassive in 13 (43.34%) and mild in 9
(26%). Of these RV dysfunction was found in 21 (70%) patients
{massive PTE 8(100%), submassive PTE 10 (76.92%), mild PTE 3
(33.34%)} when all the parameters are considered, but with TAPSE
RV dysfunction found in16 (53.34%) patients {massive PTE 8
(100%), submassive PTE 7(53.84%) and mild PTE 1(11.11%), with RV
thickness RV dysfunction was found in 20(66.67%)patients
{massive PTE 8(100%), submassive PTE9 (69.23%) and mild PTE
3(44.43%)} with myocardial velocity Rv dysfunction was found in
18 (60%) patients {massive PTE 8 (100%), submassive PTE 8(61.53%)
and mild PTE 2 (22.21%)} and with myocardial performance index
RV dysfunction was found in 17 (56.67%)patients{massive PTE 8
(100%), submassive PTE8 (61.53%) and mild PTE 1 (11.11)}. The cut-
off point of TAPSE for RV dysfunction was <1.5cm, for RV thick-
ness <0.5cm, for myocardial velocity <10.5cm/s and for MPI >0.32
was taken.
Conclusions: In PTE, RV dysfunction better detected with
tissue Doppler techniques in addition to 2D and M mode
echocardiography.Left Atrial Thrombus in a neonate with normal
heart after sustained supraventricular
tachycardia
Ravi Cherian Mathew, B. Amritha Ganesh
Mahatma Gandhi Medical College and Research Institute, Pondicherry
Left Atrial Thrombus is uncommon in neonates. We present a
neonate who had Paroxysmal Supraventricular Tachycardia
(PSVT), whose echocardiography revealed a large Left Atrial
Thrombus which resolved later with treatment. Supra Ventricular
Tachycardia (SVT) is not an uncommon event in infants with an
incidence of 1:2500.
Case report: A 28 day-old female neonate preterm, appropriate for
gestational age with a birth weight of 1.9 kg reported to our hos-
pital with a history of difficulty in breast feeding, excessive cry,
increased precordial activity and increased rate of breathing. On
examination the baby was Tachypneic with heart rate of 270/min.
Electrocardiogram (EKG) revealed Narrow QRS Regular Tachy-
cardia with a heart rate of 270/min. SVT was terminated with
adenosine bolus. EKG after termination of tachycardia showed
Sinus Rhythm with delta wave with short PR. Echocardiography
revealed a large mobile hyperechoic mass (9 mm  6 mm) from
Left Atrial Appendage (LAA) extending to body of left atrium with
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rather than a tumor. Ventricular function was normal, Atrial
function couldn’t be assessed. Blood Coagulation parameters
revealed Low Protein C Levels (46.7%) and Protein S antigen of
64.2%. Baby was initiated on Enoxaparin 1.5 mg/kg beta-blockers
and aspirin.
There were no further episodes of SVT and serial echocardiog-
raphy revealed resolving thrombus. Patient was started on
Warfarin at 0.5mg/kg. Follow up echocardiography was done at
3rd month and 6th month. Repeat ECHO at 6th month revealed
complete resolution of the thrombus. After 8 months repeat Pro-
tein C antigen was normal (102.4%) and Protein S antigen (97.3%).
Beta blockers are stopped as repeat EKG after 6months showed no
Delta waves.
In conclusion this rare case presented with a silent Left Atrial
thrombus after sustained SVT in a neonate with WPW syndrome.
The rarity of the case is LA Thrombus in an early Infant with
Structurally Normal Heart after an Episode of SVT Is Rare, with
complete resolution after 6 months and doubtful contribution of
Protein C levels.Prediction of left main and triple vessel disease
in coronary artery disease patients with no
regional wall motion abnormality using resting
longitudinal tissue Doppler strain
Rajiv Bharat Kharwar, Akhil Kumar Sharma, Ramkirti Saran,
Shudhanshu Kumar, Dwivedi Sharad Chandra, Rishi Sethi, Varun
Shankar Narain
King George’s Medical University, Lucknow, Uttar Pradesh
Background: A stress test is usually required for non invasive
echocardiographic detection of coronary artery disease, even in
left main or severe triple vessel disease, as regional wall motion
abnormalities are not always present at rest. Doppler derived
strain can be used to analyze the longitudinal component of strain
as longitudinal mechanics predominate in the ischemia e
vulnerable subendocardium. In appropriate patients at rest, sub-
clinical left ventricular dysfunction has been shown to correlate
with the presence of obstructive coronary artery disease.
Aims and objective of the study: Whether resting peak systolic
longitudinal strain (PSLS) of left ventricle using tissue Doppler
method might be useful for screening of left main or severe triple
vessel disease in patients with normal ejection fraction and no
regional wall motion abnormality.
Material and method: Fifty patients with suspected CAD (stable
ischemic heart disease, unstable angina and non ST elevation
myocardial infarction or atypical chest pain) who underwent
both, echocardiography (Vivid 7 dimension, GE healthcare) and
coronary angiography, were studied. Patients were grouped ac-
cording to the coronary angiographic findings as follows; high risk
group having left main or triple vessel disease (n ¼ 18), low risk
group with single or double vessel disease (n ¼ 20), and control
group without significant CAD (n ¼ 10). PSLS were obtained suc-
cessfully in all the segment of the left ventricle in 48 (96%) pa-
tients. There was no resting wall motion abnormality in any of the
patient. The value of PSLS was significantly low in the high risk
group (p< 0.05) especially in the mid and the basal LV segments.
Conclusion: PSLS at rest was significantly lower in patients with
left main or triple vessel disease CAD patients without regional
wall motion abnormality. This finding might be useful foridentification of patients having severe CAD before they undergo
coronary angiography.
Note: The study is ongoing with a target of achieving a total of 100
patients. Full data will be presented at the CSI 2013 if the abstract
is accepted.ElectrophysiologyA study on ventricular arrhythmias complicating
acute myocardial infarction
Selvakumaran M. S., Hemanath T. R., Sundar C., Venkatesan S.,
Dhandapani V. E.
Madras Medical College, Chennai, Tamil Nadu
Background: Ventricular arrhythmias occur in about 25% of acute
myocardial infarctions (MIs). They are associated with increased
in-hospital mortality.
Aim: The aim of this study is to identify predictors of
ventricular arrhythmias after acute MI and to determine
whether successful revascularization will reduce in-hospital
mortality.
Methods: Retrospective study of all patients who underwent
fibrinolysis for acute MI in tertiary care hospital settings between
September 2011- December 2012.
Results: Of the 465 patients who were treated with fibrinolysis
for acute MI, 23 (4.9%) developed sustained ventricular tachy-
cardia (VT) or ventricular fibrillation (VF) before revasculari-
zation. After multivariable adjustment, independent predictors
of sustained VT/VF included cardiogenic shock ( P <.001), heart
failure ( P <.001), chronic kidney disease (P¼.009), and pre-
sentation within 6 hours of symptom onset ( P¼.001). Patients
with sustained VT/VF had greater in-hospital mortality (21% vs
4.2%, P <.001). Although successful fibrinolysis was associated
with decreased in-hospital mortality in patients with VT/VF
(P <.001), patients with sustained VT/VF and successful
revascularization experienced increased mortality compared
with patients without sustained ventricular arrhythmias
(P <.001).
Conclusion: Among patients undergoing fibrinolysis for acute MI,
sustained VT/VF remains a significant complication associated
with a 4-fold increased risk of in-hospital mortality. Early mor-
tality is reduced after successful fibrinolysis, but remains elevated
in this high-risk group.Hemiazygous continuation of interrupted
inferior vena cava draining into coronary sinus
via LSVC in association with symptomatic
complete heart block
Subroto Mandal, B. Govind, P. S. S. Chowdary, G. C. Gautam, N. C.
Sarkar
LN Medical College & JK Hospital Bhopal, Bhopal, Madhya Pradesh
Background: Femoral or subclavian approach is preferred for
temporary pacemaker insertion. Rarely anatomical variations
make this procedure difficult. Anomalous continuation of IVC as
azygous or hemiazygous is rare but well described in literature.
Aims and objectives: Our aim to report a case of Anomalous
continuation of IVC as azygous or hemiazygous which is rare and
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) S 1eS 3 2 S25knowledge of this Anomaly may be beneficial for the patients
during an emergency.
Case report: A 60 year-old lady was admitted with the complaint
of multiple syncopal attacks during last 24 hrs. Her ECG showed
CHB with escape junctional rhythm with intermittent Torsades de
pointes. Shewas taken up for temporary pacemaker insertion as an
emergency under fluoroscopy. The pacemaker lead took an
abnormal route to left side of cardiac silhouette. IVC angiogram
confirmed hemiazygous continuation of interrupted inferior vena
cava draining into coronary sinus via LSVC (fig:1). Injection
through left ante-cubital vain to see the venous drainage left
subclavian vein was also draining into LSVC. Temporary pace-
maker implantation was done through right subclavian vein
which was found to be normal course and draining to right
atrium. Subsequently Permanent pacemaker was done through
epicardial approach.Fig. 1 e hemiazygous continuation of interrupted IVC
draining into coronary sinus via LSVC.Conclusion: In conclusion we report a rare anomaly of the venous
system in association with symptomatic CHB and the associated
technical difficulties. Knowledge of this anomaly may be benefi-
cial during an emergency.Is right ventricular outflow septal pacing
superior to the right ventricular apical septal
pacing with regard to long term left ventricular
function and mechanical synchrony?
Anjith Vupputuri, Gaurav Ganeshwala, K. U. Natarajan, Navin
Mathew, Rajiv C.
Amrita Institute of Medical Sciences, Kochi, Kerala
Background: Over 5 decades have transpired since the advent of
permanent pacing. Until now RV apex has been the choice of
endocardial lead placement site due to the well understood
anatomy, ease of lead placement and long term safety andstability. In the last decade, there were numerous studies and
clinical reports suggestive of long term electrical and mechanical
dyssynchrony and hence worsening of global LV function with RV
apical (RVA) pacing. Right ventricular (RVOT) septal lead place-
ment has been considered as a better and safer alternative due to
its proximity to the normal conduction system and a relatively
narrow QRS complex compared to the RVA pacing. Few studies
have shown encouraging results with RVOT septal pacing with
regard to acute and short term (up to 4 years) LV synchrony and
overall LV function. We tried to study the long term effects of
RVOT septal versus RVA pacing on LV structure, function and
mechanical synchrony.
Methods: Age and gender matched 48 patients (RV apical pacing
¼27 and RVOT septal pacing¼ 21) who were on permanent cardiac
pacing (DDD, VDD or VVI) for more than 1 year were enrolled in
the study. All these patients had structurally normal heart and
normal LV systolic functions at the time of pacemaker implanta-
tion. Baseline echocardiographic parameters were obtained from
the old records. All these patients underwent detailed echocar-
diographic assessment including dyssynchrony analysis (pulse
tissue doppler, tissue velocity imaging and speckle tracking strain
imaging). The above mentioned parameters were compared be-
tween the two groups
Results: The average duration of pacing was 6.333.2 yrs in RV
apical paced group and 3.952.43 yrs in RVOT septal paced group.
The RV apical pacing group had significantly wider QRS duration
compared to RVOT septal pacing group (152.96 ms v/s 142.38 ms).
Pulse tissue doppler, tissue velocity imaging (using time delay in
onset of systole from QRS onset in opposite LV walls) and speckle
tracking systolic radial strain analysis revealed better Intra-
ventricular LV synchrony in the RVOT paced group compared to
RVA paced group (p<0.05). The most consistent pattern of LV
dyssynchrony was seen between septum and lateral walls. The
higher ventricular dyssynchrony noted in the RVA paced group
was not related to the longer duration of pacing. There was a trend
of better inter-ventricular synchrony in the RVOT paced group
compared to RVA paced group (p¼0.07). There was no significant
variation in atrio-ventricular dyssynchrony (p¼0.71) between the
RVA and RVOT paced group. The LA dimension and MR (grade II)
were significantly higher in RVA paced group compared to RVOT
septal pacing group (p<0.04). The ventricular dyssynchrony
observed in the RVA paced group did not lead to significant
negative effects on LV dimensions, LVEF and cardiac index.
Conclusion: Our analysis has shown that long term permanent
cardiac pacing is associated with long term cardiac mechanical
dyssynchrony. In our study, RVOT septal pacing was associated
with better echocardiographic indices of inter and intra-
ventricular mechanical synchrony compared to the RV apical
pacing group. RVOT septal pacing was also found to be associated
with better parameters of LA remodelling and MR. Hence, RVOT
septum may be the preferred site over RV apical pacing in main-
taining better cardiac synchrony, till other better options are
available.Radiofrequency ablation of scar VT in ischemic
heart disease: Tertiary center experience
Sreekanth Yerram, Ajith Anantha Krishna Pillai, Raja Selvaraj,
Harichandra kumar.K. T., Geofy George
JIPMER, Puducherry
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of morbidity and mortality in patients with ischemic heart dis-
ease. Implantable cardioverter defibrillators (ICD) prevent sudden
death but recurrent VT occurs in 40-60% of patients and is asso-
ciated with increased mortality.
Objective:We report the medium term outcomes of ischemic scar
VT ablation using 3D mapping.
Methods and results: 10 patients with previous MI and VT un-
derwent radiofrequency ablation (RFA). Mean Age was 48þ-10 yrs
and nine patients were male. Four patients had old anterior wall
MI (AWMI) and six had inferior wall MI (IWMI). 3 patients had a
previously implanted ICD. CARTO was used in nine patients and
Ensite NavX in one. The mean procedure duration was 216 þ- 79
min and mean fluoroscopy time was 33þ- 20 min. The mean EF
was 36 þ- 6 %. . More than one morphology VT was induced in
three patients. Arrhythmia targeted strategy with activation and
entrainment mapping was used in four patients and a substrate
targeted strategy was used in six patients (electively in two, he-
modynamically unstable VT in three and difficult induction in
one). Mean of 32 þ- 17 ablations with a duration of 1651 þ- 804
seconds were delivered. Immediate procedural success with no
inducible sustained VT was seen in 8 patients (80%). Two patients
had one VT inducible at end of procedure, but have not had
recurrence over two years. Among the other eight patients, follow
up information ranging from 1-28 months was available in 6. One
patient had recurrent VT and underwent a second procedure that
was successful with no further events.
Conclusions: Radiofrequency ablation with the use of electro-
anatomic mapping is associated with a reasonable acute and
medium term success rate in patients with previous MI and scar
related VT.Electroanatomical mapping and ablation (3D
EAM) in idiopathic ventricular tachycardia:
Immediate and long-term outcomes
Praveen Sreekumar, Jayaprakash S., Maneesh K. Rai, Somasekhar
Ghanta, Rohit Walia, Satish S. Reddy
Sri Jayadeva Institute of Cardiovascular Sciences and Research,
Bangalore, Karnataka
Background: Catheter ablation is the treatment of choice in ven-
tricular tachycardia with a structurally normal heart. However,
Catheter ablation is often challenging as it requires a hemody-
namically stable patient during tachycardia induction and
mapping.
Objectives: To study the immediate and long term outcome of
patients undergoing 3 Dimensional Electro anatomical Mapping
(3D EAM) for ventricular tachycardia in patients with a structur-
ally normal heart.
Methods:We retrospectively analyzed clinical and procedural data
of all patientswith ventricular tachycardia and structurally normal
heart, who underwent 3 Dimensional Electro anatomical Mapping
and Ablation (3D EAM) at our centre using the CARTO system
Results: Between December 2007 and May 2013, 54 patients un-
derwent electroanatomical mapping for idiopathic ventricular
tachycardia. The mean age was 37.5  15.9 years. 37/54(68.51%)
were males and 17(31.49%)were females. 35 patients (64.8%) pre-
sented with palpitations, 21(38.8%) had syncope, while 7 (12.9)%
presented with resuscitated cardiac arrest. The distribution of the
tachycardia foci were as follows: LV free wall in 26 (48.18%)patients, Right ventricular outflow tract (RVOT) in 22 (40.71%)
patients, LVOT in 2 (3.7%)patients (right aortic cusp origin in both)
and Fascicular VT in 4 (7.41%) patients. The procedure was suc-
cessful in all cases. There were no peri-procedural complications
in any of the cases. The mean fluoroscopy time was 32.32  20.03
minutes. Fluoroscopy times were lower for LVOT and RVOT VT (18
 11.3 minutes and 22.56  14.90 minutes respectively) when
compared to LV free wall and fascicular tachycardia (41.61  21.21
minutes and 32.75  12.52 minutes respectively). After a mean
follow up of 3.4 years, recurrences were noted in 3/54(5.54%) pa-
tients (2 patients with VT originating from LV free wall and one
patient with RVOT VT). All recurrences occurred within the first 2
years of procedure.
Results: 3D Mapping offers accurate localization of the tachy-
cardia focus and results in high success rates with good long term
results and is safe.Bailout transcatheter device closure of
inadvertent ascending aorta perforation during
percutaneous transvenous mitral
commissurotomy
Mohd. Suhel Siddiqui, Prasanna Samuel, John Roshan, David
Chase, Paul V. George, Bobby John
Christian Medical College, Vellore, Tamil Nadu, India
A 12 year old girl presented with history of 2months of shortness
of breath and regular rapid palpitations, with no apparent history
of joint pains in the past. Patient was clinically diagnosed as a
patient of chronic rheumatic heart disease, severe mitral stenosis
with severe pulmonary artery hypertension and associated
tricuspid valve regurgitation. ECG revealed sinus tachcardia with
left atrial enlargement and right ventricular hypertrophy. Chest X-
ray revealed cardiothoraccic ratio of 65%, with evidence of left
heart border straightening with Right atrial enlargement and ev-
idence of pulmonary venous hypertension. Transthoraccic 2D
echocardiography revealed pliable noncalcific severe mitral valve
stenosis (area of 0.9 sq.cm), with fusion of both commissures and
mild mitral regurgitation. Interatrial septum was bulging towards
the Right atrium. Wilkinson score was 9/16.There was severe
tricuspid valve regurgitation with right ventricular systolic pres-
sure of 80 mm hg and evidence of right ventricular dysfunction.
Aortic valve was normal with no evidence of intracardiac clot.
Patient was taken for elective percutaneous transvenous mitral
commissurotomy (PTMC) with right femoral venous and arterial
access. As usual after positioning the pigtail catheter at aortic root
the Brocken borough needle was introduced through the 10 Fr
Mullins sheath which was placed in SVC and the system with-
drawn for attempted interatrial septum puncture. There was an
evident interatrial septal bulge and the site of puncture was
ascertained in both anteroposterior (AP) and left lateral pro-
jections before puncturing in left lateral view. However, inadver-
tently the aortic noncoronary cusp was pierced through the
anteriorly punctured interatrial septum in to LA in to the aorta. It
was confirmed by the aortic tracing from the mullins sheath as
well as the aortic root angiograms performed through the pigtail
catheter in Left anterior oblique, Right anterior oblique and
antero-posterior projection. Immediate 2D echo revealed same
findings with no associated pericardial effusion. Although the
patient was hemodynamically stable it was decided to seal the
defect because of the relatively large puncture through the 10 Fr
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revealed no leak across the defect and normal coronary origin.
Hence, a Cocoon duct occluder size 4/6 with aortic retention
diameter of 10 mm was planned to be deployed. Through a 6 Fr
sheath the device was loaded in to the same mullins sheath from
the right femoral vein after removal of the dilator and deployed
across the aortic perforation. Deployment was done after con-
firming appropriate position by both aortic and right ventricular
angiograms in various projections. There was no residual leak or
aortic regurgitation after deployment of device as demonstrated
by aortogram and echocardiography. The PTMC then was reat-
tempted successfully with due care about the correct site of
interatrial puncture. The postprocedure echocardiography
revealed mitral valve area of 1.7 sq.cm with mild mitral regurgi-
tation and Right ventricular systolic pressure of 45 mm hg and no
pericardial effusion. The device across the noncoronary cusp was
insitu with no residual shunt and no aortic regurgitation. Patient
was discharged after 72 hours of observation with stable hemo-
dynamic parameters.
Conclusion: PTMC is probably the most common transcatheter
valvular intervention in India. It is however imperative to assess
the proper site of interatrial septal puncture by various pro-
jections and by echocardiography especially when there is septal
bulge in to right atrium during PTMC. By timely assessment and
ingenuity device occlusion can be performed in similar cases
safely to avert a major emergency surgical procedure.Pharmacology
Evaluation of relative efficacy and safety of
prasugrel and clopidogrel in medically managed
high risk unstable angina / non STEMI ACS
population
Vikas Chaudhary, V. K. Katyal, Jasminder Singh, Kunal Mahajan,
Kapil Garg
PT BD Sharma PGIMS, Rohtak, Haryana
Background: Compared to standard dosage of clopidogrel, the
therapy with prasugrel, a potent thienopyridine P2Y (12) receptor
antagonist, have been found to be more effective in reducing the
ischemic complications in ACS patients undergoing percutaneous
coronary intervention (PCI). Similarly, the efficacy and safety of
these two antiplatelet agents, needs to be worked up, in high risk
ACS patients who are medically managed without any PCI.
Objective: This study was carried out to evaluate the relative ef-
ficacy and safety of prasugrel and clopidogrel in medically
managed high risk Unstable Angina (UA) / Non-ST Elevation
Myocardial Infarction (NSTEMI), ACS population.
Material and methods: This study was carried out in 100 consec-
utive patients of high risk UA / NSTEMI admitted to ICCU at Pt. B.D.
Sharma PGIMS, Rohtak. It was an open label prospective ran-
domized trial, where a total of 100 consecutive patients of high
risk UA / NSTEMI were studied for a period of 30 days. These pa-
tients were randomly assigned to prasugrel (40mg as loading dose
followed by 10 mg/day as maintenance dose, n¼50) and clopi-
dogrel (300 mg as loading dose followed by 75mg/day as mainte-
nance dose, n¼50)
Major adverse cardiac events (MACE) were observed during
hospital stay (0-5 days) and up to a period of 30 days after
discharge from the hospital in both the groups. Both the groupswere compared for a composite outcome of death, major/
minor bleeding episodes, arrhythmia, left ventricular
failure (LVF), recurrent angina, stroke and ischemia with ECG
changes.
Results:No patient was withdrawn from the study because of side
effects. Both the groups had 1 death each. LVF occurred in 1 pa-
tient in group-A and 3 patients in group-B (p¼non significant).
Incidence of recurrent angina was significantly lower in prasugrel
group (4% vs 16%, p <0.005). 4% of patients in prasugrel group had
progressive ECG changes because of ischemia, compared to 12% in
clopidogrel (p¼Non-significant). When the total number of MACE
are compared, they were significantly lower in prasugrel group [8
(16%) Vs 19 (38%), p <0.005] compared to clopidogrel group. When
the results were compared between a subgroup of diabetes pa-
tients in the study population (n¼5 in prasugrel group versus n¼6
in clopidogrel group), total MACE were lower in prasugrel group
than clopidogrel group (2 Vs. 7) although p value was non-
significant.
In diabetic subgroup, one patient had LVF (16.7%, n¼6) and
two patients had recurrent angina (33.3%, n¼6) in clopidogrel
group while no LVF or recurrent angina was observed in pra-
sugrel group.
Conclusion: In this analysis from our study, we have demon-
strated that in comparison to the standard clopidogrel therapy,
prasugrel resulted in greater benefit in reducing ischemic events
and improving the net outcome of ACS (high grade UA/NSTEMI)
population. Prasugrel was specially more effective in high risk
ACS population with diabetes mellitus.Cardiovascular Pharmacology
To assess evidence practice gaps amongst
patients undergoing CABG and PCI in terms of
medication prescription advice at discharge
Pradeep Pereira, Aditya Kapoor, S. K. Agarwal, Shantanu Pande,
Nirmal Gupta, Archana Sinha, Himanshu Rai, Sudeep Kumar,
Roopali Khanna, Satyendra Tewari, Naveen Garg, Gauranga
Majumdar, Bipin Chandra, Praveen Kumar Goel
Sanjay Gandhi PGIMS, Lucknow, Uttar Pradesh
Background: Despite successful coronary revascularization
guideline directed medical therapy (GDMT) should be routinely
recommended after coronary artery bypass graft (CABG) as well as
percutaneous coronary intervention (PCI). Adherence to GDMT at
hospital discharge is often sub-optimal and data pertaining to this
are lacking from our country.
Aims and objectives: A retrospective analysis to assess if pre-
scription of GDMT at hospital discharge was any different be-
tween patients following CABG and PCI.
Methods: The institutional hospital database and patient records
of last 18 months (n ¼ 1250, PCI, n¼1012,81% and CABG, n ¼
238,19%) were assessed and prescription rates of various drugs
including dosages at discharge were analyzed.
Results: Patients with CABG group were more likely to be diabetic
(48% vs 33%, p< 0.01) and hypertensive (63.4% vs 45.4% p<0.001,
while history of smoking, family history of CAD and mean lipid
values were comparable amongst the two groups. Patients in
CABG group more frequently had stable angina (65% vs. 32%,
p¼0.01, while Acute Coronary Syndrome was more frequent in
those undergoing PCI (68% vs. 35%, p¼0.01).
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differences in rate of prescription between PCI and CABG groups
for dual anti-platelet therapy (aspirin 100% in both, clopidogrel
100% vs 98%), beta blockers (98% vs 95%) and statins (100% vs.
99%). In contrast, ACEI and Nitrates were more frequently pre-
scribed post-PCI vs. CABG (97.9% vs. 62.3%, p<0.001 for ACEI; 61.3%
vs. 2.6%, p<0.001 for nitrates respectively). Interestingly, despite
similar mean baseline LVEF, diuretics were prescribed more
frequently after CABG (95% vs.7%, p<0.001). Prasugrel and Tica-
grelor were only prescribed in post PCI patients.
Doses of drug used: Aspirin (75mg OD, 150mg OD, 300mgOD) was
prescribed equally commonly in both groups, with 150 mg OD
being themost common dose (89.7 vs 98.3%). Clopidogrel 75mg BD
was the most commonly used dose post PCI (68% vs 0%), while
post CABG it was only prescribed as 75 mg OD. Patients under-
going PCI weremuchmore likely to receive higher statin dose (36.8
vs 13.5 mg, p< 0.001). Prescription rates for 40-80 mg statin was
76%vs0% while that for 10 mg was 3%vs79% for PCI and CABG
respectively (p<0.001). Prescription of beta blockers (50mg) was
more common post PCI (85% vs 58%) while 25 mg was more
frequently prescribed post CABG (33%vs10%, all p< 0.01).
Conclusions: Significant differences in adherence to GDMT at
hospital discharge exist even in a tertiary care centre. Patients
were less likely to receive high dose statin or higher doses of beta
blockers and more likely to receive diuretics (irrespective of
baseline EF) following CABG. Following CABG, 5% of patients were
not prescribed beta blockers and 1/3rd did not receive ACEI at
discharge. Such evidence practice gaps need to be rectified to
further improve quality of cardiac care in CAD patients following
revascularization.Valvular Heart DiseaseEchocardiographic follow-up study of immediate
and long term outcomes of balloon mitral
valvotomy for rheumatic mitral stenosis
Jugal Sharma, P. K. Goel, Aditya Kapoor, Satyendra Tewari,
Naveen Garg, Sudeep Kumar, Roopali Khanna
Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow,
UP-226014
Background: Rheumatic heart disease (RHD) is a major public
health problem in India and mitral stenosis is the most frequent
form of valvular affliction in RHD with significant morbidity &
mortality. Balloon mitral Valvotomy (BMV) is a safe and effective
therapeutic modality for managing such patients.
Aims and objectives: To retrospectively analyse the immediate
and long term outcome after BMV performed at a tertiary centre.
Methods: Case records of 2330 patients who underwent BMV form
June 1999 to December 2005 were analysed.
Results: Mean patient age was 33  11 yrs (range 8 to 80), 58.5%
were females and 15.2% (n¼355) were in atrial fibrillation (AF) at
the time of the procedure. Most patients included in the analysis
had undergone BMV for the first time, while 1.8% (n¼43) were post
BMV restenosis and 2.7% (n¼63) were restenosis following closed
mitral valvotomy (CMV).
The procedure was successful in 92.7% of patients as defined by
achieving mitral valve area  1.5 cm2 or more with no more than
grade 2 Mitral regurgitation (MR). Among procedural complica-
tions, 5.3% (n¼123) developed new MR, 4.5% (n¼104) developedworsening of pre-existing MR, 0.5% (n¼12) developed tamponade
and 7.0% (n¼162) had residual ASD. Overall, 0.5% (n¼12) died, 0.7%
(n¼16) underwent in-hospital Mitral valve replacement (MVR), 1
patient sustained ischemic Cerebrovascular accident (CVA) due to
embolism while 0.2% (n¼5) patients developed peripheral
embolism.
After a successful BMV, survival free of restenosis, re-do BMV,
MVR and death was 97.9%, 86.8%, 60.0% and 45.4% at 1 yr, 5 yr, 10
yr and 13 yr respectively.
Patients with Normal sinus rhythm (NSR) and those who ach-
ieved valve area > 1.7 cm2 had significantly better survival as
compared to patients with AF (NSR-10.9 yrs, 95% CI 10.6-11.2 vs
AF-9.1yrs, 95% CI 8.5 e 9.7, p ¼ <0.001) and those who achieved
valve area between 1.5- 1.7 cm2 (MVA>1.7- 11.36, 95% CI 11.07-
11.66 vs MVA 1.5-1.7 e 10.09, 95% CI 9.74-10.45, p ¼ <0.001).
Patients with AF demonstrated 96.3%, 79.7%, 46.2% and 31.2%
event free survival rates at 1yr, 5 yr, 10 yr and 13 yrs of follow-up
respectively whereas the corresponding event free survival rates in
patients with NSR were 98.2%, 88.1%, 62.3% and 48.3 % respectively.
Patients who achieved valve area 1.5-1.7 cm2 showed 99%,
83.8%, 53.4% and 33.5% event-free survival at 1 yr, 5 yr, 10 yr and 13
yrs of follow-up respectively whereas those with valve area  1.7
cm2 showed survival rates of 98.2%, 95.4%, 73.4% and 65.2 % at
respective follow-ups.
Conclusion: After an initial successful BMV, long term survival
from restenosis, MVR and death though excellent at 5 years (86.8%),
is only modest (45.4%) at 13 years. Patients with sinus rhythm had
better long term outcomes as compared those with AF (48.3% vs
31.3% at 13 years). Patients who achieved an immediate post BMV
valve area  1.7 cm2 had the best long term outcomes.Apixaban versus warfarin in patients with atrial
fibrillation and valvular heart disease: Finding
from the Aristotle study
A. Avezuma, R. D. Lopesb, P. J. Schulteb, F. Lanasc, M. Hannad, P.
Paise, C. Erolf, R. Diazg, C. B. Grangerb, J. H. Alexanderb
aDante Pazzanese Institute of Cardiology, Sao Paulo, Brazil: bDuke
Clinical Research Institute, Duke University Medical Center, Durham,
North Carolina, United States of America: cUniversity of La Frontera,
Temuco, Cautı´n Province, Chile: dBristol-Myers Squibb, Princeton, New
Jersey, United States of America: eSt. John’s Medical College, Bangalore,
India: fAnkara University, Ankara, Turkey: gEstudios Cardiologicos
Latinoamerica (ECLA), Rosario, Santa Fe, Argentina
Aim: Apixaban is indicated for the prevention of stroke and
systemic embolism (SE) in pts with nonvalvular AF. In this
context, valvular refers only to clinically significant mitral ste-
nosis (MS) and not other valvular heart disease (VHD). Little is
known about the efficacy and safety of apixaban in pts with AF
and VHD.
Methods: We used data from 18,197 pts with AF and 1 risk
factor for stroke in ARISTOTLE with available information on
VHD. Pts with clinically significant MS and mechanical heart
valves were not eligible. Of these, 4808 (26.4%) had VHD defined
by any history of at least moderate mitral regurgitation (3526),
MS (131), aortic regurgitation (887), aortic stenosis (384),
tricuspid regurgitation (2124), or valve surgery (251). We
compared the effect of apixaban vs. warfarin on rates of stroke
or SE and major bleeding in pts with and without VHD using
Cox proportional hazards modeling.
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bleeding, had a higher mean CHADS2 score, and had less hyper-
tension and diabetes than pts without VHD. Pts with VHD had
higher rates of stroke or SE and bleeding than pts without VHD.
The benefits of apixaban compared with warfarin in reducing
stroke and SE (interaction p¼0.38), causing less major bleeding
(interaction p¼0.23), and decreasing death (interaction p¼0.10)
were consistent irrespective of the presence of VHD (Fig).
Conclusions: Pts with AF and VHD are at high risk for thrombo-
embolic events and bleeding. Apixaban was similarly efficacious
and safe in AF pts with and without VHD. Additional research is
needed on the efficacy and safety of apixaban in pts with AF and
VHD, particularly those with clinically significant MS and me-
chanical prosthetic valves.Immediate and short term outcomes of balloon
aortic valvuloplasty e Tertiary care experience
Chndramohan, Santhosh Satheesh, Balachandar J.
JIPMER, Puducherry
Background: Balloon Aortic Valvuloplasty (BAV) has definitive role
as safe palliative treatment in severe symptomatic aortic stenosis
and as a bridge to definitive therapy. Renewed interest in this
procedure is seen with significant advances in transcatheter
aortic valve implantation. BAV relieve aortic stenosis by
commissural splitting in congenital and rheumatic aortic steno-
sis, whereas in degenerative calcific aortic stenosis it do so by
fracture of nodular calcium. This study analyse safety and effec-
tiveness of BAV for severe aortic stenosis of various etiology and
here we report single centre experience of 116 cases in 13 years.
Methods: This retrospective study included 116 patients of severe
symptomatic aortic stenosis with mean gradient >50 mm Hg
assessed by echocardiography. All patients of aortic stenosis of
various etiology like congenital, rheumatic and degenerative
calcific aortic stenosis was included in study from 1997 to June
2013. BAV was done as bridging to definitive therapy, as a pallia-
tive treatment for symptomatic relief and also as a part of mul-
tivalvular intervention in rheumatic aortic stenosis. All patients
underwent BAV by retrograde approach. After crossing the ste-
notic aortic valve peak to peak transvalvular gradient was
measured and left ventriculogram performed routinely to assess
left ventricular function and aortic annulus size. Stepped balloon
diameter was used in all cases for dilatationwith rapid ventricular
pacing. Post procedure 50% reduction in transvalvular peak to
peak gradient was considered as successful result, < 50%reduction as partially successful and little or no reduction in
gradient despite maximal balloon dilatation as unsuccessful
result.
Results: Out of 116 Patients, 6 (5.2%) had failure to cross stenotic
aortic valve and hence procedure abandoned. Of the patients who
underwent BAV 56%(n¼ 65) were males and 44%(n¼51) were fe-
males. 22.4%(n¼26) were children under 18 years of age. Mean age
was 28 years (range 1 year to 56 years). 32.7% (n¼38) had Rheumatic
heart disease with severe aortic stenosis in addition tomitral valve
involvement. 45.6%(53) had congenital aortic stenosis with
morphologically bicuspid aortic valve. One patient with subaortic
membrane underwent successful procedure. 5%(n¼6) had calcific
degenerative aortic stenosis, remaining 15.5%(n¼18) had severe
aortic stenosis ofuncertain etiology. Steppedballoonwasutilized inall (90% cribier latec and 10% NuMed Tyshak). The mean fall in
transvalvular peak to peak gradient was from 106.338 mm Hg to
32.0419.94 mmHg (P<0.0001). Procedure was successful in 84.8%,
partially successful in 12.12% and unsuccessful in 3%. There was
good immediate and short term result as evidenced by symptom-
atic relief and significant fall in transvalvular gradient. Overall,
Aortic regurgitation occurred in 37.2%(n¼41), Moderate aortic
regurgitation in 18.1% (n¼20),and severe aortic regurgitation in
4.2%(n¼5). 2.5% had pericardial effusion (n¼3). One patient had
cardiac tamponade. 1(0.9%) patient died of left ventricular posterior
wall perforation. Vascular complications occurred in 0.9%(n¼1). Six
month follow up available for 92 patients. Four patients with
rheumatic aortic stenosis underwent DVR. Two patients with
calcific AS underwent AVR. Increase in the mean gradient at 6
months was from 32.0419.94 mmHg to 4524.4 mm Hg.
Conclusion: BAV in our series was done for Congenital, Rheumatic
and Degenerative aortic stenosis with good immediate and short
term results underscoring its efficacy and safety for palliative and
bridging therapy in the treatment of severe symptomatic Aortic
stenosis.Prevalence of coronary artery disease in patients
with rheumatic heart disease: Does RHD protect
from cad??
Ramakrishnudu, Maddury Jyotsna, Abhishak Tripati,
Madhavapeddy Aditya
Nizam, Hyderabad, Andhra Pradesh
Background: RHD continues to be one of the major CV diseases in
developing countries whereas CAD is the most common cause of
CV mortality worldwide. However it is not well known how the
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We wanted to analyse whether presence of RHD has any impact
on prevalence of CAD.
Methods:We retrospectively analysed the data of all RHD patients
(Group A ) of 30 to 70 yrs age , without conventional modifiable
coronary risk factors (RF) (like HTN, DM, smoking, dyslipidemia,
obesity), not a known case of CAD, who underwent CAG in our
institute from Jan 2012 to Dec 2012. During same period same age
group patients without above said RFs or CAD or RHD (Group B)
were also analysed. CAD was insignificant if luminal stenosis was
<50% & significant if it was >50%.
Results:53RHDpatients [16 (30.19%)males, 37 (69.81%) femaleswith
mean age 47.313.5 yrs.] and 370 CAD patients [214 (57.84%) males,
156 (42.16%) females with mean age 50.215.8 yrs.] who filled the
inclusion criteria were analyzed. In Group A, 37 females, 36 (97.3%)
had normal coronaries (NC) & 1 (2.7%) had insignificant CAD. None
of them had significant CAD. Similarly out of 16 males, 15 (93.75%)
had NC & 1 (6.25%) had significant CAD. In group B, 156 females, 86
(55.13%) had NC, 22 (14.1%) insignificant CAD & 48 (30.77%) had
significant CAD. Out of 214 males, 38 (17.76%) had NC, 48 (22.43%)
insignificant CAD & 128 (59.81%) had significant CAD. In the same
age group , despite of difference in the gender, the chi square anal-
ysis showed significant association of the CAG finding (normal,
insignificantand significant indecreasingorder) andRHD (p¼0.000).
For classification of data in terms of severity of CADandpresence or
absence of RHD, Spearman’s rho correlation coefficient test showed
negative correlation to the occurrence of RHD and CAD (Sperman’s
rho¼ -0.21 with P¼ 0.003). Means Group A (patients with RHD) had
significantlyhigher incidenceofnormalcoronariesandsignificantly
lower incidence of significant CAD as compared to Group B of same
age group despite more females were there in Group A.
Conclusions: RHD appears to protect from significant CAD in the
absence of coronary RFs.Prognostic significance of newly acquired bundle
branch block after aortic valve replacement
T. De, D. Kahali, A. Mishra, K. K. H. Siddiqui, J. C. Sharma
B.M. Birla Heart Research Centre, Kolkata, West Bengal
Background: The prognosis of bundle branch block (BBB) that
occurs after aortic valve replacement was studied retrospectively
Aims & objectives: To determine the prognostic significance of
postoperative bundle branch block after aortic valve replacement.
Method: 200 patients who had aortic valve replacement in our
institution over the last 3years were studied. The effect of BBB on
the combined end point of syncope, atrioventricular block and
sudden cardiac death was studied during 3years of followup.
Result: Of the 200patients, 30 had preoperative BBB, 40 developed
new BBB postoperatively. The event rate during follow-upwas 1.5%
in thesewithout BBB and 18% in thosewith post-operative BBB. The
adverse event rate was higher both in those with pre-existing and
new postoperative BBB. Multivariate analysis indicated that a new,
persistent postoperative BBB was an independent predictor of
adverse. Events during follow up. The highest event rate occurred
among thosewith new left BBB and left axis deviation after surgery.
Most adverse events occurred during the first year of follow-up.
Conclusion: A new, persistent BBB acquired after aortic valve
replacement surgery significantly increases the risk of adverse
events, especially during the first postoperative year. Prophylactic
pacemaker implantation should be considered for these patients
after surgery.Cardiac Surgery
Release kinetics of cardiac biomarkers in
patients undergoing valve replacement surgery
for rheumatic heart disease
Satyajeet Singh, Aditya Kapoor, S. K. Agarwal, Shantanu Pande,
Archana Sinha, Himanshu Rai, Sudeep Kumar, Satyendra Tiwari,
Naveen Garg, Gauranga Majumdar, Bipin chandra, P. K. Goel
Sanjay Gandhi PGIMS, Lucknow, Uttar Pradesh
Background: Levels of brain natriuretic peptide (BNP) increase
following CABG and predict post-operative outcomes. Release ki-
netics of BNP, Troponin-I (TnI) and CKMB after valve replacement
are not well characterized.
Methods: We assessed levels of these biomarkers 24 hours prior
and 6,24, 48 hrs, 1 month following mitral/aortic valve replace-
ment in 50 patients (mean age 36.7 yrs, LVEF 54.4%, 80% males).
Results:Mean baseline BNP, TnI and CK-MB levels were 304.01 pg/
ml, 0.03 ng/ml and 0.99 ng/ml. BNP initially decreased within 6
hours of surgery, and peaked at 24 hours; TnI and CKMB showed
an early rise, with declining trends by 24 hrs. Peak BNP levels
occurred in 90% patients by 24-48 hrs, while for TnI and CKMB this
occurred in only 15-30%. Mean delta (peak-baseline) BNP, TnI,
CKMBwas 660.1pg/ml, 8.1ng/ml and 32.3ng/ml. At 1 month, levels
of all biomarkers were not significantly different from baseline.
Patients with higher baseline BNP more commonly had atrial
fibrillation (71vs 33%, p¼.02), higher right ventricular systolic
pressure (69.7vs43.9 mm Hg, p< 0.001),higher Euroscore
II(2.42vs1.49,p¼0.006),longer inotrope duration (56.1vs26.5hrs,
p¼0.03), ventilator support time (35.6vs21.7 hrs, p¼0.04), longer
ICU (4.8vs3.2 days, p¼0.02) and hospital stay (6.8vs5.2 days,
p¼0.03). Inotrope duration>42 hrs, ventilation time>29 hrs and
ICU stay>4 days was seen in 42%vs19%, 30%vs9% and 33%vs14%
respectively in patients with baseline BNP / 200 pg/ml. Only
baseline BNP was a significant predictor of inotrope duration
(p¼0.01) and ventilation time (p¼0.02). Only 24 hour post-
operative BNP and delta BNP were predictors of inotrope
duration>42 hrs, ventilation time>29 hrs and ICU stay>4 days.
Conclusion: Release kinetics of cardiac biomarkers following
valve surgery are significantly different from each other. Of all the
biomarkers, only BNP levels had an association with post-
operative inotrope duration, ventilation time and ICU stay in pa-
tients undergoing valve replacement.Miscellaneous
Clinical presentation and management
strategies of tubercular pseudoaneyrsm arising
from large arteries: A tertiary care centre
experience
Rakendra Singh, Bishav Mohan, Praneet Wander, Rohit Tandon,
Shibba Takkar Chhabra, Naved Aslam
Dayanand Medical College, Ludhiyana, Punjab
Background: Tubercular pseudoaneurysm (PSA) is a rare but
important complication of tuberculosis. Aortic pseudoaneurysm
are the most commonly described while data on involvement of
other large arteries being sparse.
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) S 1eS 3 2 S31Aims & methods: To discuss the clinical presentation and man-
agement strategies of tubercular PSA arising from large arteries
other than aorta.
Methods: 26 consecutive cases of PSA of large arteries from
January 2003 to December 2010were analyzed. Out of which active
tuberculosis was found as etiological cause in 4 patients (22 to 65
years). Arteries involved were Superficial femoral artery (SFA),
Profunda femoris artery (PFA), and in two cases lobar branches of
Pulmonary Artery (LPA). 3 patients had tubercular lymphadenitis
in close vicinity to site of PSA, one patient presented with miliary
tuberculosis, whereas both patients of LPA PSA had evidence of
active/ treated pulmonary tuberculosis. Presentation was with
Massive hemoptysis and new onset swelling in the groin. 2 pa-
tients deemed unfit for endovascular repair due to infection and
skin necrosis underwent vascular surgery with venous interpo-
sition graft. 2 patients were treated via endovascular approach
using PDA occluder device. All 4 patients received anti- tubercular
therapy in the peri and post intervention period.
Results: All patients survived the intervention and were dis-
charged from the hospital. At mean follow of 36 months (with
maximum of 4 years) patients remained free from symptoms and
repeat intervention.
Conclusions: High index of suspicion is needed to timely diagnose
this rare and potentially fatal entity. A combination of chemo-
therapy and surgical/endovascular approach yields gratifying re-
sults in its management.Profile and outcomes of cardiac tamponade:
Experience from a tertiary care center
Ramya Pechetty, D. Seshagiri Rao, A. N. Patnaik, O. Sai Satish,
B. Srinivas, Rama Kumari, Barik, Lalitha, Suresh, Siva Prasad
Nizam Institute of Medical Sciences, Hyderabad, Andhra Pradesh
Objectives: To evaluate the clinical profile, etiology and outcomes
in patients with cardiac tamponade.
Methods: Data was collected retrospectively from 2009 until Aug
2012 and prospectively from Aug 2012 to Aug 2013.Only patients
with significant pericardial effusion with tamponade were
included. Demographic details, procedural details, complications
and outcomes were recorded.
Results: Total of 92 patients were analysed. 55 were men (59.7%) &
37 were women (40.3%). Mean age was 34 yrs. Various etiologies
were TB 23.9%(22), malignancy 16.3%(15), Procedure related
14%(13), Inconclusive 12%(11), Connective tissue disorders 8.6%(8),
CKD 8.6%(8), hypothyroid 7.6%(7), pyogenic 5.4%(5), PostMI 2.1%(2)
& Eosinophilic 1%(1). Pericardiocentesis was done bedside under
echo guidance in 70 %( 64) and under fluoroscopy guidance in 29
%( 27). In 1 patient bedside procedure was unsuccessful and
needed surgical assistance (0.01%). Based on etiology sub group
analysis was done. Of the patients with TB etiology, 19 were men
(86%). Mean age was 30 yrs. Mean ADA was 98.6 IU/dl. Mean
duration of pigtail was 4.5 days & there were no deaths. Malignant
effusion was seen in 15 patents.11 were men (73.3%). Mean age
was 36yrs. Among those in the first decade 3 out of 5 had malig-
nancy (60%). Of them, adenocarcinoma of lung wasmost common
40%(6). Others were lymphoma in 33.3%(5), ALL in 13%(2),breast
carcinoma in 1%(1) and oesophageal Cancer in 1%(1).Pericardial
fluid cytology showed malignant cells in 11 patients(73%). Mean
ADA was 101 IU/dL. Mean duration of pigtail insertion was 5.8
days. Re positioning was needed in 3 patients. Re insertion was
needed in 2 patients. No deaths occurred. Among the 13 procedurerelated causes of cardiac tamponade, 10 were men (76.9%). Mean
age was 42.1yrs. Most common cause was post MVR 69.2%(9
patients-8 had anticoagulant induced bleed & 1 had infection with
MRSA). Others were Post PTCA in 15.3%(2),Post PBMV in 7%(1) and
ASD closure 7%(1). Death occurred in 4 patients (30%), of which 2
were post MVR and 2 were post PTCA patients. In 5 patients
infective cause of tamponade was found. Mean age was 37.6 yrs. 3
were men (60%). Pyopericardium (MRSA culture positive) in 2 pa-
tients, myopericarditis in 2 patients and IE with Burkholderia
cepacia with aortic root abscess in 1 patient. 2 patients died (40%).
Overall mortality was 7 %( 7 patients). Of these 4 were procedure
related, 2 were pyogenic cause, 1 was in inconclusive group and
none were pericardiocentesis related.
Conclusions: The most common cause of cardiac tamponade is
Tuberculosis, followed closely by malignant effusions. Younger
the age more was the chance of being malignant effusion. Overall
mortality was 7%. Infective and post procedure associated cardiac
tamponade showed highest mortality. Pericardiocentesis is a safe
procedure whether done bedside or under fluoroscopic guidance.Assessment of endothelial dysfunction in
patients with chronic kidney disease and
changes following renal transplantation
Jugal Sharma, Aditya Kapoor, Narayan Prasad, Sudeep Kumar,
Naveen Garg, Satendra Tiwari, Roopali Khann, R. K. Sharma,
P. K. Goel
Sanjay Gandhi PGIMS, Lucknow, Uttar Pradesh
Background: Endothelial function is an important antecedent for
atherosclerosis. Patients with chronic kidney disease (CKD) have
an increased cardiovascular risk and endothelial dysfunction has
been postulated to explain this association. Whether endothelial
function is different in patients with CKD managed medically or
on dialysis and improves after renal transplantation (RT) needs
further investigation.
Aims and objectives: To assess endothelial function patients with
CKD on medical therapy and maintenance hemodialysis (HD) by
imaging the brachial artery during reactive hyperemia (endothe-
lium-dependent or flow mediated dilatation, FMD) and glyceryl
trinitrate-induced dilatation (NMD, endothelium-independent
dilation). Endothelial function was also assessed prior to RT and
3 months following RT.
Methods: A total of 103 patients of CKD were included (mean age
39.314.4 yrs, range 5-75 yrs). FMD and NMD were calculated as
the percent change in diameter compared to baseline and
impaired FMD was defined as values < 4.5%.
Results: Hypertension was present in 94/103 (91.3%), diabetes
mellitus in 24 (23.2%) and associated angiographic proven CAD in
7 (7.2%), mean echocardiographic LVEFwas 55.910.8%. Themean
Hb was 8.61.8 mg/dl while mean serum creatinine was 6.82.6
mg/dl and mean eGFR was 13.4þ13.2 ml/min/1.73m2, range 4.5-
91.8.
At enrollment, 14 patients (14.4%) were on medical therapy,
while 89 (85.6%) were on HD. During the study period, 74/89 (83%)
underwent RT, and of these a follow up (post RT) assessment of
FMD/NMD was performed in 40 patients.
Assessment of endothelial function: Endothelial dependent (FMD)
was significantly lesser (mean 9.236.9%) as compared to NMD
(19.89.4%, p < 0.001). An impaired FMD (< 4.5%) was observed in
28/103(26.7%); in contrast, impaired NMD was observed less
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) S 1eS 3 2S32commonly (only in 4.3%). There was no difference inmean FMD or
NMD amongst males vs females, those aged </>30 years and
those with/without diabetes. Mean FMD in patients on medical
therapy was slightly lower as compared to patients on HD,
although this was not statistically significant (8.78.8% vs
9.36.7%). The NMD values in these two groups were comparable.
There was a significant improvement in mean FMD in patients
following RT (10.57% to 14.47.2%, p¼0.04). However mean NMD
values did not change significantly following RT (20.68.2% to
22.59.2%, p¼ns).
Conclusions: Patients with CKD frequently have endothelial
dysfunction as evidenced by low FMD, while endothelium inde-
pendent (NMD) is usually preserved. Patients of CKD on medical
therapy had slightly lower FMD as compared to those on HD.
Following RT, while NMD values did not change significantly,
there was a significant improvement in FMD within 3 months of
successful renal transplantation.Procedural implications of persistent right
innominate artery tortuosity during right
transradial or trans ulnar coronary interventione
A prospective case controlled study
T. Ghose, U. Kaul, R. Kachru, R. Gupta, P. S. Sandhu, S. Sayal,
A. Hussain, A. Shiraz I
Fortis Flt. Lt. Rajan Dhall Hospital, New Delhi
Background: Increased tortuosity of innominate artery is
sometimes encountered during right transradial (RTR) or tran-
sulnar (RTU) coronary interventional procedures. We named
this sign as Tapan sign (TS). We conducted a multicenter pro-
spective controlled study to evaluate the procedural implica-
tions of TS.
Methods: Between July 2012 & May 2013,all the patients under-
going RTR & RTU interventions were studied. Presence of TS was
recognized by the M pattern or inverted W pattern of the
guidewire or catheter during the passage of the catheter from
right innominate artery to aorta (Group A). If the sign dis-
appeared during deep inspiration the cases were excluded. The
randomly selected angiographic procedure done by the same
operator in the same cath lab on the same day, served as con-
trols (Group B).Demographic variables, procedural time(PT),total
fluoroscopy time(FT), dose area product(DAP), cumulative air
kerma(AK) & contrast dosage(CD) utilized were noted in both
Group A&B.
Results: 20 patients were identified with TS. In 2 cases the TS
disappeared with inspiration. Complete data was not available in
2 (Group A 1, Group B 1). In 1 case control could’t be found. The
demographic variables were comparable between the groups
(Group A, n¼15, 3 RTR, mean age 65.86þ8.17 yrs, 8 males, diabetes
mellituse3, hypertensione4, smokinge3, dyslipiaemiae4; Group
B n¼15,2 RTU, mean age 73.75þ5.62 years, 7 males, diabetes
mellituse4, hypertensione3, smokinge4, dyslipiaemiae5).
Femoral conversion was required in two patients in group A. Thetotal PT was higher in Group A (42þ13.2 min vs 25þ11 min;
p¼0.032). The FT was 14.05þ6.86 min versus 6.03þ3.65 min
(P¼0.011). DAP was 105595.75þ66413.76 mGy cm2 versus
35001.25þ36617.83 mGy Cm2 (P¼0.02), cumulate AK (mGyAK) was
1802.26þ10.47.391 versus 710.69þ590.65 (P¼0.022) & the CD usage
was 83.75þ31.48 versus 56.25þ11.87 ml (P¼0.037) in group A & B
respectively.
Conclusions: From this multicentre controlled study we conclude
the presence of TS suggestive of tortuous right innominate artery
during RTR or RTU interventional procedures is associated with
significantly higher total PT, FT, radiation exposure & RC
requirement. Switch over to a femoral approach would be the
prudent approach in such cases.Study of mitral valve apparatus in formalin fixed
hearts with special reference to the scallops of
posterior mitral leaflet
Kaku Singh Bhatia, Abhijeet Yadav, Asha Dixit, B. S. Yadav,
Yogesh Varma
Gandhi Medical College, Bhopal, Madhya Pradesh
Background: This studywas conducted for detailed analysis of the
anatomy of posterior mitral leaflet (PML) with special reference to
scallops. The number and dimensions of the cusps and the scal-
lops have a particular significance in Mitral valve prolapse and
resultant regurgitation. Review of literature shows that anterior
mitral leaflet (AML) is not divided into scallops. PML is divided into
scallops and there are variations in the number and size of scal-
lops of the PML.
Aims & objectives: 1) To study the anatomy of mitral valve com-
plex in with special reference to scallops. 2) To measure average
dimensions of valve structures including scallops.
Material &methods:Mitral valve structure including the length of
leaflets, number of scallops on leaflets and the lengths of each
scallop was noted in 40 formalin fixed hearts in the Department of
Anatomy and the mean values were calculated. The presence of
any accessory cusps was also noted. Hearts with any valvular
pathology were excluded.
Results: In formalin fixed hearts, no accessory cusps were seen in
mitral valve. Anterior mitral leaflet (AML) was not divided into
scallops. Posterior mitral leaflet (PML) was found to have 2-4
scallops. 74% hearts had 3 scallops, 20% had 4 and 6% had 2
scallops in PML. Length of posteromedial commissural scallop
was more in 2 scalloped PML (1.25  0.07 cm in males and 1.30 
0.08 cm in females), length of middle commissural scallop was
more in 3 scalloped PML (1.27  0.18 cm in males and 1.24  0.19
cm in females) & length of anterolateral commissural scallop was
more in 4 scalloped PML (1.13  0.34 cm in males and 1.13  0.15
cm in females).
Conclusions: Normal human heart has scalloped PML. The num-
ber of scallops varies from 2-4, with 3 scalloped PML being the
most common. All the dimensions of scallops were lesser as
compared to western data.
